6-23CURRICULUM VITAE

Kenneth Dale Burman, M.D.

Office:                                                                                                  110 Irving Street NW, Suite 2A-72

                                                                                                  Washington, DC 20010

                                                                                                  (202) 877-6563

                                                                                                  Kenneth.D.Burman@MedStar.net

Wife’s Name                                                                                    Mary Eileen (Molly)

Children’s Names                                                                      Edward Matthew

                                                                                                  Stephen Joseph

                                                                                                  Andrew Clarkson

                                                                                                  David Alexander

                                                                                                  Emily Scott

EDUCATION:

              Washington University (St. Louis) A.B., 1966

              University of Missouri Medical School, M.D., 1970

              Barnes Hospital Internship 1970-1971, Internal Medicine

              Barnes Hospital Residency 1971-1972, Internal Medicine

              Walter Reed Army Medical Center Fellowship Endocrinology 1972-1974

PROFESSIONAL SOCIETIES:

              American Federation for Clinical Research, 1973

              Member, American College of Physicians, 1974

              Missouri Certification Examination, 1970

              Licensure: Missouri, Washington, D.C., Maryland

              Attending Physician, DC General Hospital, Howard University Service, 1975

              American Medical Association, 1972

              American Thyroid Association, 1975

              Member, Endocrine Society, 1976

              Fellow, American College of Physicians (FACP), April 1979

              American Association of the Advancement of Science, 1982

              American College of Nutrition, 1983

              Institute of Nutrition, 1984

              American Society for Clinical Nutrition, 1984

              American Association Immunologist, 1985

              Society of Medical Consultants to the Armed Forces, 1991

              Academy of Medicine, 1993

              American Association of Clinical Endocrinologists, 2000

              Menopause Society, 2003

              National Lipid Association, 2010

              Alliance for Academic Medicine (AAIM) 2013

              Association of program Directors in Endocrinology and Metabolism (APDEM) 2006

BOARD CERTIFICATION:

              National Medical Boards Parts I, II, III, Certified, 1971

              American Boards of Internal Medicine, June 1973

              Board Certification, Endocrinology and Metabolism, October, 1975

              American Board of Nutrition - Certified as a Specialist in Clinical Nutrition, 1984

ACADEMIC APPOINTMENTS:

              Professor of Medicine, Georgetown University, Washington, DC

              Professor of Medicine, Unformed Services University of the Health Sciences,

              Bethesda, MD

              Clinical Professor, Department of Medicine and Surgery (Otolaryngology), Georgetown               University School of Medicine, Washington, DC

              Clinical Professor, Department of Medicine, George Washington University School of               Medicine, Washington, DC

Assistant Chief, Endocrine Service, Walter Reed Army Medical Center, Washington, DC (1978 - 1991)

Assistant Commandant for Students, Uniformed Services University of the Health Sciences, Bethesda, MD (1980-1984).

              Consultant to the Surgeon General of the US Army in Nutrition (1985-1991)

              Consultant in Endocrinology to the Attending Physician’s Office, The Capitol,                             Washington, DC (1985-1994)

Chief, Endocrinology, Uniformed Services University of the Health Sciences, Bethesda, MD (1991 - 1994)

Director, Endocrine Training Program, Walter Reed Army Medical Center, Washington, DC (1991-1994).

              Director, Section of Endocrinology, MedStar Washington Hospital Center, Washington, DC

              (1994 - Present)

Director, Integrated Endocrine Training Program, MedStar Georgetown University Hospital/ MedStar Washington Hospital Center, Washington, DC (2002-present).

Regional Director, Endocrine, Medstar, Washington, DC (2016-present)

HONORS AND AWARDS:

1976              Fellow, American College of Physicians

1982              Peter Forsham Award, given to the individual in government service who is performing               outstanding research

1984              Van Meter U.S.V. Award, given by the American Thyroid Association for outstanding               contributions to our understanding of thyroid disease

1985              American Federation for Clinical Research, Eastern Section Young Investigator Award,

              1985, for outstanding contributions in research concerning the causes of thyroid disease

1986              Alpha Omega Alpha

1986          American Society of Clinical Investigation

1987              The Claire Chennault Award given to an Outstanding Teacher, Walter Reed Army               Medical Center

1989              Distinguished Physician Award given to graduate of University of Missouri Medical School who has contributed significantly to medical research and patient care

1997               Laureate, American College of Physicians

1997              Vicennial Medal, Georgetown University, for teaching and patient care

1998               Member, American Thyroid Association Council

2001          Distinguished Alumni Award, University of Missouri.

2004               Awarded Mastership in the American College of Physicians

2007              Barbara and William James Howard Award for Academic Excellence, Washington Hospital Center

2007              Paul Starr Award for Career Excellence in Clinical Research, American Thyroid Association

2007              Board, American Thyroid Association (2007-2010),

2008                President, American Thyroid Association (2008-2009).

2010              Deputy Editor, Journal of Clinical Endocrinology and Metabolism (2010-2015).

2010              Overholser Award Lecture, Physician Alumni Organization, University of Missouri Medical School.

2011              Dr. John Dunn Lecture, University of Virginia Medical Center, Charlottesville, VA.

2011              Dr. Leon P Georges Lecture, Eastern Virginia Medical Center, Norfolk, VA.

2013               Dr. Walter Lester Henry Award for Lifetime Excellence in Teaching, American College of Physicians, DC Chaper.

2014              Golden Cane Award for Clinical Expertise, Medstar Washington Hospital Center

2016              John Stanbury Thyroid Pathophysiology Medal which recognizes outstanding research contributions, either conceptual or technical, to the understanding of thyroid physiology or the pathophysiology of thyroid disease, as evidenced by having a major impact on research or clinical practice related to thyroid diseases.

2017              Citation of Merit, University of Missouri Medical School; awarded to an outstanding graduate.

2019     Outstanding Educator Award, Endocrine Society Annual Meeting

2021              Braverman Award, American Thyroid Association, given to individual who has demonstrated excellence and passion for mentoring fellows, students and junior faculty, has a long history of productive thyroid research and is devoted to the ATA.

2022              Endocrine Grand Rounds, UCLA, Los Angeles (Virtual)

SELECTED COMMITTEES:

1981 -               Present                                           Reviewer for VA Grants

1982 -               Present              Ad Hoc               Reviewer for NIH Grants

1985     Present Ad Hoc               Reviewer for Canadian Grants

1982    Ad Hoc                                           Endocrine Society Representative to National Academy of Science Committee on Health Manpower Needs

1983                                                        American Thyroid Association - Constitutional Ad Hoc Committee on revising the by-laws

1983 - 1990                                           Endocrine Society - Future meetings committee

1983                                                         Reviewer for National Science Foundation Grants

1984   Ad Hoc                                          Reviewer for Heritage Scientific Foundation, Alberta, Canada

1984 - 1986                                           Chairman, Society of Uniformed Endocrinologists

1986 - 1991                                           Chairman, Future Meetings Committee, Endocrine Society

1987                                                        Finance Committee, American Thyroid Association

1987                                                        Co-Chairman, Local hosts, American Thyroid Association

1987                                                        Coordinator, Clinical Nutrition Course, USUHS

1988                                                        Ad Hoc Review, grants, American Diabetes Association

1988                                                        Program Committee, American Society of Clinical Nutrition

1988                                                         Awards Committee, American Thyroid Association

1988                                                        Cholesterol Advisory Group to the Surgeon General

1988 - 2000                                           Abstract reviewer, Endocrine Society, American Thyroid Association

1989                                                        Chairperson, By-Laws Committee, American Thyroid Association

1989                                                        Program committee, American Thyroid Association

1990                                                        Reviewer for Veterans Administration Merit Review and for Allegheny-Singer Foundation

1990                                                        Chair, Subcommittee on International Meetings, Endocrine Society

1991                                                        Organizer, American Thyroid Association Symposium, Bethesda, MD

1992                                                        Member, Education Committee, American Thyroid Association

1993                                                        Search Committee for Radiology Chairperson, USUHS, Bethesda, MD

1993 - 1994                                          Co-chair, Human Use Committee, Department of Clinical Investigation, Walter Reed

1999                                                    Clinical Initiatives Committee, Endocrine Society

1999- 2002                                           Scientific Advisory Board, Novavax, Inc.

2001                                                        Local Organizer, American Thyroid Association Meeting

2001                                                        Chair, Public Health Committee, American Thyroid Association

2002                                                        Advisory Board, Thyroid Cancer Support Group

2002                                                        Advisory Board, Thyroid Foundation of America

2003-present                                          Scientific Review Board, General Clinical Research Center,

Georgetown University Medical Center; CTSA Grant Scientific Review Board

2007-2015                                          FDA Advisory Committee (Endocrine and Metabolism)

2008-2010                                          Chair, FDA Advisory Committee (Endocrine and Metabolism); ad hoc member 2011 -

2008                                                        Consultant to the Endocrine Society's Hormone Foundation website

2007-2010                                          Board of Directors, American Thyroid Association

2008-2009                                          President, American Thyroid Association

2009              Consultant to Medical Letter

2007-2010              Endocrine Society, Laureate Award Committee

2011              Professor Evaluation Committee, Harvard University

2010              American Thyroid Association Anaplastic Thyroid Cancer Guideline       Committee

2011              American Thyroid Association Levothyroxine Replacement Committee

2000-2011              Thyroid Cancer Support Group (ThyCa) Consultant

2008-2011              Endocrine Fellows Foundation Grant Reviewer

2011              Endocrine Society Poster Judge

2010-              American College of Physicians MKSAP Committee

2010-              Medscape, Consultant

2005-              UpToDate, Consultant, Author

2011-              Academic Promotions Committee, Georgetown University

2010-              Glycemic Control Committee, MedStar Washington Hospital Center

2011-              Council, Association of Specialty Professors (ASP) (AAIM)

2012-              Chair, Spring Thyroid Hormone Symposium, American Thyroid Association

2009-2012              American Thyroid Association Anaplastic Thyroid Cancer Guideline

              Committee

2013-2018              American Thyroid Association, Finance Committee

2013-2018              International Thyroid Oncology Group (ITOG), Finance and Ethics Committee (Ad Hoc)

2013-              Lombardi Comprehensive Cancer Center, Clinical Research Committee, Georgetown University

2013-              Grant Review Committee, Endocrine Fellows Foundation

2015-2018              Chair, Finance Committee, American Thyroid Association

2015-2020              Development Committee, American Thyroid Association

2015-2016              LEAD Program Mentor, Medstar

2017,2023              FDA Endocrine Advisory Committee

2023-              Protocol Committee, International Thyroid Oncology Groupt (ITOG)

2023-              History and Archives Committee, American Thyroid Association

2023-              Thyroid Cancer Re-Differentiation Committee.Society of Nuclear Medicine

SELECTED INVITED LECTURES:

1976                                                        Symposium on Anorexia Nervosa, NIH, Bethesda, MD

1977                                                         University of Missouri Medical Center, Columbia, MO

1981                                                        Massachusetts General Hospital, Boston, MA

1981                                                        Guthrie Clinic, Sayre, PA

1980, 1982                                          Endocrine Society Course in Radio Ligand Techniques, Bethesda, MD

1980                                                        Conference on Thyroid Hormones, Tucson, AZ

1981                                                        Medical Grand Rounds, National Naval Medical Center, Bethesda, MD

1982                                                        International Workshop on Hormone Assays and Standard, NIH, Bethesda, MD

1982                                                        Medical Grand Rounds, George Washington Medical Center, Georgetown University and NIH, Bethesda

1983                                                        Visiting Professor in Endocrinology, Fitzsimmons Army Medical Center, Aurora, CO

1983                                                        Geisinger Clinic, Danville, PA

1983                                                        American Thyroid Association Annual Meeting, Sept. 1983

1983                                                        Wayne State University Thyroid Symposium, Detroit, MI

1984                                                        Van Meter Address, American Thyroid Association, New York, NY              

1984                                                        American College of Physicians Regional Meeting, San Francisco, CA

1984                                                        Guthrie Clinic, Sayre, PA

1984                                                        Beth Israel Hospital, Boston, MA

1985, 1987, 1998                            Johns Hopkins Medical Center, Baltimore, MD

1985                                                        Young Investigators Award Address, American Federation of Clinical Research, Baltimore, MD             

1986                                                        Medical College of Virginia

1992                                                        Graves’ Ophthalmopathy Symposium, Washington Hospital Center, Washington, DC

1988                                                        Visiting Professor, Dalhousie University, Halifax, Nova Scotia, Canada

1991                                                        Visiting Professor, Montreal General Hospital, McGill University, Montreal, Quebec, Canada

1991                                                        Medical Grand Rounds: George Washington University Medical Center, Washington, DC

1991                                                        Visiting Professors, Samuel Haines, Lectureship, Mayo Clinic, Rochester, MN

1991                                                        Invited Speaker, Autoimmune Thyroid Symposium, Montreal, Canada

1992                                                        Invited Speaker, The Royal College of Physicians and Surgeons of Canada, Canadian Society for Endocrinology and Metabolism, Annual Meeting, Ottawa, Canada

1992                                                        Invited Speaker, Northern Virginia Institute for Continuing Medical Education Conference

1993                                                        Immunology Council, Johns Hopkins University Medial Center, Baltimore, MD

1993                                                        University of Michigan Medical Center, Ann Arbor, MI

1993                                                        Geisinger Clinic, Danville, PA

1993 - 2010                                          NIH Endocrine Board Review Course

1997 - 2003                                          Endocrine Society Board Review Course

1994                                                        Thyroid Workshop, Portsmouth, VA

1995                                                        Thyroid Workshop, Boston, MA

1996                                                        Endocrine Course, Charlotte, NC

1997                                                        Endocrine Course, Charleston, SC

1998                                                        Endocrine Course, Milwaukee, WI

1999                                                        North Atlantic Endocrine Society, Bar Harbor, ME

1999                                                        Beth Israel Medical Center, New York, NY

1999                                                        Abbington Memorial Hospital, Philadelphia, PA

2000                                                        University of Maryland, Bethesda, MD

2000                                                        Georgetown University, Washington, DC

2001                                                        Beebe Medical Center, Dewey DE

2001                                                        Princeton Medical Center, Princeton, NJ

2001                                                        University of Virginia, Charlottesville, VA

2001                                                        Walter Reed Army Medical Center, Washington, DC

2003                                                        East Carolina University, Greenville, NC

2003                                                        Brown University, Providence, RI

2003                                                        Moses Nussbaum Lectureship, Beth Israel Hospital, NY, NY

2003                                                        Abbott Lecture, Sinai Hospital, Baltimore, MD

2004                                                         American Thyroid Association, Vancouver Canada

2005                                                        American Association of Clinical Endocrinologist, Washington, DC

2005                                                        Ohio State University, Columbus, OH

2005                                                        Marshall University, Huntington, WV

2005                                                         Dartmouth University, Hanover, NH

2006-present                                          American College of Physicians Board Review

2006                                                        Lankenau Hospital, Philadelphia, PA

2007                                                        Walter Reed Army Medical Center, Washington, DC

2007                                                        Lankenau Hospital, Philadelphia, PA

2007                                                        Paul Starr Award Plenary Lecture, American Thyroid Association Meeting, New York City.

2002-present                                          NIH Board Review Course, Bethesda, MD

2008                                                        Endocrine Society, Clinical Endocrine Update, Boston, MA

2009                                                        University of Miami, Florida

2009                                                        European Thyroid Association, Lisbon, Portugal

2010                                                        University of Louisville, Louisville, KY

2006-present                                          American College of Physicians Board Review

2010                                                        J.S.L.Browne Lecture, McGill University, Montreal, CA

2010                                                        Christiana Hospital, Wilmington, DE

2010                                                        Sinai Hospital, Baltimore, MD

2010                                                        Endocrine Society, San Diego, CA

2010                                                        Mid-Atlantic Meeting, American Association of Clinical Endocrinologists, Rockville, MD

2010                                                        Plenary Lecture, American College of Physicians (Military Section), Bethesda, MD

2010                                                        International Thyroid  Meeting, Paris, France

2011                                                        University of Maryland Medical Center, Baltimore, MD

2011                                                        University of Virginia Medical Center, John Dunn Visiting Professor,

                                                    Charlottesville, VA

2011                                                        Eastern Virginia Medical Center, Leon P. Georges Visiting Professor,

                                                        Norfolk, VA

2011                                                        New York Thyroid Club, Manhattan, NY

2011                                                        Case Management Forum, Endocrine Society Annual Meeting, Boston, MA

2011-present                                          Frontiers in Reproductive Endocrinology, Washington, DC

2012                                                        American College of Physicians Certification Course and Re-Certification Course, (2006-2012)

2012                                                        Midatlantic Meeting, Society of Nuclear Medicine, Washington, DC

2013                                                        Visiting Professor, University of Connecticut, Farmington, CT.

2013                                                           Meet The Professor Session, T3, T4, or Both? Endocrine Society, San Francisco, CA, June, 2013

2013                                                        Chair, Assessment of Recurrent/Persistent Cervical Node Thyroid Cancer, World Thyroid Cancer Congress, Toronto, CA.

2013                                                        Chair, Symposium on Graves’ Disease, American Thyroid Association Annual Meeting, San Juan, Puerto Rico

2013                                                        St. Agnes Hospital, Baltimore, MD

2014                                                        Visitng Professor, Department of Medicine, Yale University, New Haven,CT

2014                                                        Visiting Professor, Boston University, Boston, MA

2015                                                        Visiting Professor, Lankenau Medical Center, Philadelphia, PA

2015                                                        Medical Grand Rounds, Howard University, Washington, DC

2015                                                        Lecture on “Recurrent cervical papillary thyroid cancer” at the

                                                        International Thyroid Congress, Orlando, FL.

2015                                                        Thyroid Nodules, Howard University, Washington, DC

2016                                                        Thyroid Nodules and Thyroid Cancer, Medstar Harbor Hospital

2016-                                                           Hypothyroidism and Thyroiditis, NIH/FAES Board Review Course

2017                                                        Recurrent Thyroid Cancer, World Cancer Thyroid Congress, Boston, MA

2022                                                        Endocrine Grand Rounds, UCLA, Losa Angeles, CA (virtual)

2022                                                        Medicine Gand Rounds, VA Hospital, Washington, DC

REVIEWER:

American Journal of Physiology

Annals of Internal Medicine

Achieves of Internal Medicine

Autoimmunity

Endocrine Related Cancer

Endocrinology

Immunology & Immunopathology

International Journal of Obesity

Journal of the American Medical Association

Journal of Clinical Endocrinology and Metabolism

Journal of Clinical Investigation

Journal of Clinical Pharmacology

Journal laboratory and Clinical Medicine

Mayo Clinic Proceedings

Metabolism

Thyroid

American Journal of Physiology

Clinical Endocrinology

Cancer Control:  Journal of the Moffitt Cancer Center.

Endocrine Related Cancer

Journal of Clinical Oncology

New England Journal of Medicine

Endocrine Related Cancers

Endocrine Practice

EDITORIAL BOARD:

Journal of Clinical Endocrinology and Metabolism, January 1980 - December 1984;

January 00-04

Deputy Editor, Journal of Clinical Endocrinology and Metabolism 2010-2015

Thyroid, 1991 - Present

Endocrinology and Metabolism, 1995 – 1999

Reviews in Endocrine and Metabolic Disorders, 2006

SELECTED COMMUNITY ACTIVITIES:

Commissioner, Montgomery County Soccer League

Antiquarian Book Fair, Concord Hill School, Bethesda, MD

Advisory Committee, Stone Ridge School, Bethesda, MD

Landon School, Bethesda, MD - Health Committee, Education Committee, Computer Committee, Board of Trustees

ABSTRACTS:

1. Burman KD, Klachko D, Senhauser DD, Burns TW, Sharp CG.  Hashimoto’s Thyroiditis Associated with an Unusual Pattern of Thyroid Autoantibodies.  Clinical Research XVIII, p. 256, 1970.

2. Burman KD, Fox JD, Earll JM, Wartofsky L.  Sources of Increasing Serum T3 in Newborn Sheep.  American Thyroid Association, Inc. 50th Meeting, September 1974.

                            Endocrinology (Suppl) 93: T-21, 1974.

3. Burman KD, Yeager H, Briggs B, Wartofsky L.  Resin Hemoperfusion: A Potential New Treatment for Thyroid Storm, The Seventh International Thyroid Association Meeting, Abstract 93, June 1975, Boston, MA.

4. McGuire RA, Burman KD, Wartofsky L, Berman M. Compartmental Models for Maternal, Fetal, and Amniotic Fluid Transfer of Iodine, Triiodothyronine and Thyroxine in the Pregnant Sheep.  Endocrine Society Meeting, Abstract1 142, June 1975.

5. Burman KD, Read J, Wright FD, Earll JM, Wartofsky L.  Thyroid Function in Amniotic Fluid.  American College of OB-GYN Meeting, May 1976.

6. Burman KD, Dimond RC, Earll JM, Wartofsky L.  Sensitivity to Lithium in treated Graves’ Disease.  Presented at American College of Physicians Meeting, April 1976.

7. Boehm TM, Burman KD, Wartofsky L.  Synergistic Effects of Lithium and Iodine in the Treatment of Hyperthyroidism.  Endocrine Society Meeting, 618, June 1976.

8. Burman KD, Dimond RC, McGuire RA, Earll JM, Strum D, Wartofsky L.  The Effect of Varying Serum T4 Concentrations on Extra thyroidal Production of T3, Reverse T3, and 3-3' Diiodothyronine.  Clinical Research 24:270, 1976.

9. Burman KD, Strum D, Dimond RC, Djuh YY, Earll JM, Wartofsky L.  A Radioimmunoassay for 3,3' T2.  Program 52nd Annual Meeting, American Thyroid Association Toronto.  Endocrinology 98:7-17, 1976.

10. Smallridge RC, Wartofsky L, Desjardins RE, Burman KD.  Reverse T3 Production Rates in Thyrotoxic, Euthyroid and Hypothyroid Subjects.  Clinical Research 25: 302A, 1977.

11. Becker RA, Wilmore DW, Johnson DW, Burman KD, Wartofsky L.  Alterations in Peripheral Thyroid Economy and Pituitary Responsiveness in Thermally Injured Man.  Clinical Research 26:14A, 1978.

12. Becker RA, Johnson BW, Wilmore DW, Burman KD, Wartofsky L, Woeber KA.  Alteration in Serum T3 and Reverse T3 in Thermal Injury.  Clinical Research 24:270A, 1976.

13. Georges LP, Burman KD, Czerwinski C, Sode J, Wartofsky L.  The Effect of Sedation and Awakening on Peripheral Thyroid Hormone Levels in the Subhuman Primate.  Clinical Research 25:13A, 1977.

14. Wannemacher RW, Dinterman RE, Burman KD, Wartofsky L. The Possible Role of Thyroid Hormone in Regulating the Rates of Protein Degradation in Skeletal Muscle.  Federation Proceedings 37:1315, 1978.

15. Wray HL, Burman KD, Smallridge RC, Alford JP, Wartofsky L.  Effects of T3 and Reverse T3 Administration on Serum Tri-, Di-, and Monoiodothyronines in Sheep.  Federation Proceedings 37:519, 1978

16. Smallridge RC, Wartofsky L, Dimond RC, Burman KD.  3', 5’-diiodothyronine and 3'-monoiodothyronine: Development of Radioimmunoassays and Demonstration of in Vivo Peripheral conversion.  Annual Endocrine Society Meeting, June 1978, Abstract 102.

17. Glass AR, Mellitt R, Burman KD, Swerdoff RS, Wartofsky L, Fisher DA.  Effect of Dietary Composition on Serum T4 and T3 in Rats.  Clinical Research 26:283A, 1978.

18. Wray HL, Burman KD, Alford JP, Wartofsky L.  Effect of T3 and rT3 Administration on Plasma CAMP and GMP in Sheep.  Clinical Research 26:16A, 1978.

19. O’Brian JT, Bybee D, Wartofsky L, Georges LP, Burman KD.  Altered Peripheral Thyroid Hormone Metabolism and Diminished Hypothalamic Pituitary Responsiveness with Changes in Dietary Composition.  Clinical Research 26:310A, April 1978.

20. Latham KR and Burman KD. Physiologic and Chromatographic Evidence for Separate T3 and T4 Receptors. American Thyroid Association, September 1978.

21. Smallridge RC, Ward K, Wartofsky L, Burman KD. 3,’5'T2 to 3"T1 Conversion in Rat Liver and Solubilization of Multiple Phenolic Ring Deiodinases.  American Thyroid Association, September 1978.

22. Bybee D, Taub M, Burman KD, Wartofsky L, Georges LP, O’Brian JT.  The Effect of Hypocaloric Carbohydrate Feeding on Central and Peripheral Thyroid Hormone Regulation.  Clinical Research 26:611, 1978.

23. Burman KD, Djuh YY, Kesler P. Wartofsky L.  The Effect of T4 Administration on Hepatic Conversion of T4 to T3 in States of altered Carbohydrate Economy.  Annual meeting of Endocrine Society, Miami, Florida, Abstract 327, June 1978.

24. Zwillich C, Martin B, Rose E, Charles A. Hofeldt F, Burman KD.  The Effects of Dense Beta Sympatheic Blockade on Metabolic Rate and Thyroid Function in Normal Man.  Clinical Research 27:263A, 1979.

25. Wannemacher RW, Dinterman RE, Burman KD, Wartofsky L.  Thyroid Hormone: A Regulator of Protein Degradation in Skeletal Muscle.  11th International Congress of Biochemistry, Toronto, Canada, 8-13, July 1979.

26. Burman KD, Smallridge RC, Jones L, Ramos EA, O’Brian JT, Wright FD, Wartofsky L. Glucagon Kinetics in Fasting: A Metabolic Event Associated with Physiologic Alterations in Serum T3.  Clinical Research 27:284A, 1979.

27. Burman KD, Smallridge RC, Osbune R, Dimond RC, Whorton NE, Kesler P, Wartofsky L.  Nature of Suppressed TSH Secretion During Undernutrition: Effect of Fasting and Refeeding on TSH Responses to TRH infusion.  Clinical Research 27:248, 1979.

28. Smallridge RC, Latham KR, Ward KE, Wartofsky L, Burman KD.  Conditions Affecting 3', 5'-diiodothyronine (3', 5'T2) to 3'-monoiodothyronine (3'T1) Conversion: Evidence for an Enzyme Separate from Thyroxine (T4) and Reverse T3 (rT3) 5'-deiodinase.  Clinical Research 27:260A, 1979.

29. Latham KR, Smallridge RC, Tseng YL, Burman KD, Wartofsky L.  Nuclear Thyroid Hormone Receptors in Heart and Liver: Long-term Effect of Hypo and Hyperthyroidism.  Clinical Research 27:255A, 1979.

30. Pangaro L, Smallridge RC, Cahnmann HJ, Wright FD, Burman KD.  Development of a Radioimmunoassay for 3,5T2 and demonstration of Conversion from T3.  Endocrine Society Poster Session, Los Angeles, California, June 1979.

31. Burman KD, Latham KR, Djuh YY, Smallridge RC, Tseng YC, Lukes YG, Maunder R, Wartofsky L.  Solubilized Nuclear T3 and T4 Receptors in Circulating Human Mononuclear Cells: Evidence for Increased Maximum Binding Capacities in Fasted Obese Subjects.  Presented at the Endocrine Society, Los Angeles, California, June 1979.

32. Osburne RC, Bybee DE, O’Brian JT, Burman KD, Wartofsky L, Georges LP, Sensitivity of the Hypothalamic pituitary Axis to Triiodothyroxine in the Underfed State.  Clinical Research, January 1980.

33. Smallridge RC, Smith CE, Wright FD, Wartofsky L, Burman KD.  Metabolic Clearance and Production Rates of 3'5'T2 in Hyper-and Hypothyroidism.  Comparison of Infusion Using labeled Versus Unlabeled Hormone.  61st Annual Meeting of the Endocrine Society Anaheim, California, Abstract 74, 13-15, June 1979.

34. Burman KD and Wartofsky L.  The Effect of Dexamethasone, and Diet in Hepatic T3 Murine Receptors.  Thyroid Foundation Seminar, Tucson, Arizona, October 1980.

35. Burman KD, Djuh YY, Latham KR, Wartofsky L.  White Cell T3 Receptors Decrease in Critical Illness.  Clinical Day, Annual Thyroid Association Meeting, Sand Diego, California, 5 November 1980.

36. Bongionvanni R, Burman KD, Boehm T.  Measurement of Iodothyronines by HPLC. Annual Thyroid Association Meeting, San Diego, California, November 1980.

37. Chernow B, Burman KD, Johnson DL, O’Brian JT, Wartofsky L, Georges LP.  Iodothyronines Bi-directional Transfer Across the Blood Brain Barrier.  Clinical Meeting, San Diego, California, 5 November 1980.

38. Hay ID, Jiang NS, Burman KD, Gorman CA.  Inner Versus Outer Ring Monodeiodination of Orally Administered D- or L-thyroxine in man. Clinical research, May 1981.

39. Rajagopal KR, Derderian SS, Jabbari B, Burman KD, Hunt KK.  Obstructive Sleep Apnea in Hypothyroidism.  American Thoracic Society, 1981.

40. Borst GC, Premachandra BN, Osburne RC, Burman KD, Johnsonbaugh RF.  Euthyroid Familial Hyperthroxenemia Due to an Abnormal Thyroid Hormone-Binding Protein.  Endocrine Society, 1981.

41. Fear W, Burman KD, Wartofsky L, Latham KR.  Acetylase Activity in Rat Liver Nuclei in Euthyroid, Hyperthyroid and Hypothyroidism.  American Thyroid Association, September 1981.

42. Pangaro L, Little J, Gerris B, Burman KD.  Modulation of Plasma Membrane Thyroid Hormone Receptors.  American Thyroid Association, September 1981.

43. Glass AR, Smallridge RC, Vigersky R, Burman KD.  High Serum T3 in Nephrotic Syndrome: A Reflection of Increased T4 Availability?  Clinical Research 1982.

44. Smallridge RC, Whorten NE, Burman KD, Ferguson EW.  Effect of Physical Conditioning and Acute Exercise on Serum T4, rT3, TSH and PRL Responses to TRH in Man.  Endocrine Society, June 1982.

45. Borst GC, Burman KD, Osburne RC, Georges LP, O’Brian JT.  Effect of Fasting in TRH Responsiveness in Hypothyroidism.  Military Society of Endocrinology.  San Francisco, June 1982 and American Thyroid Association Meeting, Quebec, Canada, September 1982.

46. Burman KD, Wartofsky L, Smallridge RC.  Ipodate Restores the Fasting Induced Decrement in TSH Secretion.  European Thyroid Association, Brussels, Belgium, September 1982.

47. Wartofsky L, DeRuyter H, Smallridge RC, Burman KD. Thyrotropin Secretion in Starved Rats is Enhanced by Somatostatin Antiserum.  European Thyroid Association, Brussels, Belgium, September 1982.

48. Chernow B, Zaloga G, Burman KD, Quinn A, Rainey T, Zajtchuk R. Chariopulmonary Bypass Surgery Rapidly Alter Thyroid Function.  Clinical Research 31:257, 1983.

49. Chernow B, Zaloga G, Burman KD, chin R, Zajtchuk R.  Diagnostic Dosages of TRH Raise Blood Pressure by a Noncatecholamine Mechanism.  Clinical Research 31:257, 1983.

50. Glass AR, Vigersky RA, Burman KD.  Divergent Effects of Nephrotic Syndrome on Metabolic Clearance Rate of T4 and T3 in Rats.  Clinical Research 31:470, 1983.

51. Michenfelder J, O’Brian JT, Burman KD, Georges LP.  The Influence of Thyroid Hormone in the Excretion of Catecholamines and their Metabolities during Semi-Starvation.  Annual Air Force Physicians Meeting, San Antonio, TX, March 1983.

52. O’Brian JT, Michenfelder J, Burman KD.  The Effect of Cold Climate upon T4, T4 and TSH Responses to TRH.  Annual Air Force Physicians Meeting.  San Antonio, TX, March 1983.

53. Baker J, Lukes YG, Smallridge RC, Burger M, Burman KD.  A Sensitive and Rapid Enzyme-linked Ammuno-sorbent Assay (ELISA) for Thyroid Stimulating Hormone Receptor Antibodies.  Clinical Research 269, 1983.

54. Chernow B, Zaloga GP, Burman KD, Chin R, Zajtchuk R, Rainey TG, Lake CR.  Diagnostic Dosages of TRH Raise Blood Pressure by a Non-catecholamine Mechanism.  Society of Critical Care Medicine Annual Meeting, New Orleans, LA, June 1983.

55. Burman KD, Djuh YY, Ferguson RW, Wartofsky L, Latham KR.  Beta Receptors in Peripheral Mononuclear Cells Increase Acutely during Exercise.  Endocrine Society, San Antonio, TX, Abstract 472, June 1983.

56. Baker JR, Lukes YG, Burman KD.  Class of Antibodies Binding the Thyroid Stimulating Hormone Receptor in Active Graves’ Disease.  Submitted to the American Thyroid Association presentation, Abstract 3, Sept. 1983,

57. Burman KD, Djuh YY, Baker JR.  Circulating Beta Ligand Antibodies in Auto-immune Thyroid Disease.  American Thyroid Association Annual Meeting, poster, Abstract 65, Sept. 1983.

58. Reed HL, Burman KD, George P, O’Brian JT.  Thyroid Economy in cold Adaptation of Euthyroid Volunteers.  Endocrinology 112:A1150, 1983.

59. Reed HL, Burman KD, Shakir KMM, O’Brian JT.  Reduced Effect of Oral T3 on TSH Response to TRH after Antarctica Cold Exposure.  Clinical Research 32:689, 1984.

60. Raines KB, Baker Jr.JR, Lukes YG, Burman KD.  Functional Characterizations of Anti-Thyrotropin Antibodies in the Sera of Graves’ Patients.  American College of Physicians Annual Meeting, Atlanta, GA, April 1984.

61. Baker Jr JR, Lukes YG, Burman KD.  Production, Isolation and Characterization of Anti-idiotypic Antibodies Directed against Human Anti-TSH Receptor Antibodies.  Clinical Research, May 1984.

62. Chernow B, Snyder R, Zaloga GP, Burman KD.  Angiotensin-Converting Enzyme Activity and Thyroid Function Decrease Acutely in Critical Illness.  Clinical Research, 32:253A, 1984.

63. Zaloga GP, Chernow B, Zajtchuk R, Hall K, Hargraves R, Burman KD, Smallridge R, Lake CR.  Critical Illness Decreases Thyrotropin Responsiveness to Thyrotropin-releasing Hormone - A Potential Cause of Misinterpretation of Thyroid Function Tests in Critically Ill Patients.  Critical Care Medicine, 12:235, 1984.

64. Burman KD, Smallridge RC, Wartofsky L.  Iodide Administration Enhances Thyrotropin Responsiveness to TRH During Fasting: Evidence for Normal Pituitary Feedback Regulation.  7th International congress of Endocrinology, Quebec, Canada, A538, July 1984.

65. Burman KD, Luke Y, Wartofsky L, Djuh Y, Baker J Jr.  Preparation of Biotinylated Receptor-Purified Graves’ IgG: A Simple Technique Allowing Direct Functional Assessment of TSH Receptor Antibody Interaction with Membranes.  Satellite Symposium, 7th International Congress of Endocrinology, Journal of Steroid Biochemistry, 20:L-29, June 1984.

66. Baker J Jr., Wright C, Sadoff J, Burman KD.  The Development of Monoclonal Antibodies Directed against Anti-TSH Receptor Antibodies.  Satellite Symposium, 7th International Congress of Endocrinology, Quebec, Canada, Journal of Steroid Biochemistry, 20:L-30, June 1984.

67. Burman KD, Baker Jr JR., Lukes YG, Djuh YY, Peters JB, Grandlund D, Dembrow D. Wartofsky L.  Characterization of a Monoclonal Antibody Developed against the TSH Receptor.  The American Thyroid Association, Sixtieth Meeting, New York, NY, T-25, Sep 1984.

68. Baker Jr JR, Raines KB, Lukes YG, Burman KD.  Anti-TSH Antibodies in the Sera of Graves’ Patients Which Display Anti-Idiotypic Activity against TSH Receptor Purified Graves’ IgG.  The American Thyroid Association, Sixtieth Meeting, New York, NY, T-37, Sep 1984.

69. Hennessey JV, Burman KD, Wartofsky LW.  Equivalency of Two Brand Name L-thyroxine Preparation.  Association of Military Physicians, Dayton, OH, Mar 1985.

70. Baker JR, Engler RJM, Burman KD, Djuh Y.  Beta-adrenergic Binding Antibodies (BLA) in Adult, Steroid Dependent Asthmatics.  Presented to American Academy of Allergy and Immunology, 1985.

71. Zuker a, Chernow B, Fields AI, Hung W, Burman KD.  Evaluation of Thyroid Function in Critically Ill Children.  Critical Care Medicine Meeting, 1985.

72. Baker Jr JR., Wartofsky L, Wortsman J, Burman KD.  TSH Receptor Antibody and Anti-idiotypic Antibody Containing Immune Complexes in Graves’ Disease.  Clinical Research, 33:307A, 1985.

73. Weetman AP, Volkman DJ, Burman KD, Margolick JB, Petrick P, Weintraub B, Fauci AS.  Induction of Ia Antigens on Thyroid Cells and Autoantigen Presentations in Graves’ Disease.  Clinical Research, 33:391A, 1985.

74. Glass AR, Anderson J, Burman KD, Decreased Serum Triiodothyronine (T3) in Underfed Rats: Adaption to Chronic Calorie Deficiency.  Clinical Research, 33:307A, 1985

75. Sack J, Baker Jr JR., Wartofsky L, Weetman AP, Volkman D. Margolick J, Burman KD.  Natural Killer Cells in Hashimoto’s Thyroiditis.  Endocrine Society Program, Abstract 724, 1985.

76. Sack J, Baker Jr JR., Weetman AP, Wartofsky LW, Burman KD.  The Role of Antibody Dependent Cytotoxicity and natural Killer Cells in Hashimoto’s Disease.  Presented at International Thyroid Meeting, Sao Paolo, Brazil, Sept., 1985

77. Whorton NE, Burman KD, Smallridge RC.  Angiotensin-Converting Enzyme Activity, Reduced in Fasted Human, is not Corrected by T3 Administration.  Endocrine Society, Abstract 1316, 1985.

78. Baker JR, Saunders, NB, Burman KD.  Human Monoclonal Antibodies Derived from Peripheral blood Lymphocytes of Graves’ Disease Patients which Inhibit both TSH and Graves’ IgG-mediated production of CAMP.  Clinical Research.  34:433A, 1986.

79. Sack J, Burman KD, Dwyer D, Zilberstein D.  Thyrotropin-binding Proteins in Leishmania: Serum Antibodies in Patients with Auto-immune Thyroid Disease Directed Against Specific Parasite Membrane Antigen.  Clinical Research 34:433A, 1986.

80. Baker JR, Wartofsky L, Burman KD.  Mouse Monoclonal Antibodies to Human Thyrocyte Membrane Proteins which Augment both TSH and Graves’ IgG-mediated Production of Cyclic Adenosine Monophosphate (CAMP).  Clinical Research 34:421A, 1986.

81. Miller FW, Baker Jr JR., Burman KD, Steinber AD.  Thyroid-stimulating and Thyrotropin binding-inhibiting Immunoglobulins in Patients with Systemic Lupus Erythematosus (SLE).  Proceedings of the International Congress of immunology, Toronto, July 1986.

82. Tseng Y-C, Burman KD, Baker JR, D’Avis J, Wartofsky L.  Intrinsic Abnormality of Thyroid Cells from a Brobdingnagian Goiter.  Endocrine Society Meeting, Abstract 834, 1986.

83. Sack J, Zilberstein D. Barile MF, Wartofsky L, Dwyer D, Burman KD.  Characterization of Thyrotropin binding Proteins in Mycoplasma: Serum Antibodies Directed against a Specific Mycoplasma Membrane Determinant in Patients with Auto-immune Thyroid Disease.  Endocrine Society Meeting, Abstract 834, 1986.84.  Ahmann A., Baker JR, Weetman AP, Wartofsky L, Nutman T, Burman KD.  Serum Immunoglobulins in Patients with Graves’ Ophthalmopathy Directed against Unique Determinants in Porcine Eye Muscle.  Clinical Research 34:420A, 1986.

84. Weetman AP, Nutman TB, Burman KD, Smallridge RC.  Sustained Thyroid Autoimmunity in Subacute Thyroiditis (SAT).  Fifth Joint Meeting of British Endocrine Societies, 1986 and European Thyroid Association, Stockholm, June 1986.

85. Weetman AP, Smallridge RC, Hayslip C, Burman KD.  Multiple Autoantigenic Determinants in Thyroid Autoimmunity.  International Symposium, Thyroid Autoimmunity, Pisa, Italy, November 1986 and European Thyroid Association, Stockholm 1986.

86. Weetman AP, Baker J, Burman KD.  Thyroid Autoantigen Heterogeneity Demonstrated by Immunoblotting.  Medical Research Society Meeting, Clinical Science. June 1987

87. Johnson K, Rinke W. Burman KD.  Comparison of Circumference, Skinfold, Bioelectrical Impedance and Hydrodensitometry to Estimate Percent Body Fat during Weight Loss.  FASEB Meeting, Spring 1987.

88. Reed HL, Bryce D, Shakir KM, Burman KD, O’Brian JT.  Human Thyroidal and Cardiovascular Responses to Prolonged antarctic Residence.  Federation Proceedings 46:332, 1987.

89. Kikendall JW, Burman KD, Johnson LF.  Esophageal Function in Early Hypothyroidism.  American Gastroenterology Association, 1987.

90. Burman KD, Djuh YY, LaRocca RV, Israel MA, Nunes ME, D’Avis JC, Nicholson DE, Helman LJ, Wartofsky, L.  C-myc Expression in Normal, Adenomatous, and Cancerous Thyroid Tissue.  Presented at American Thyroid Association National Meeting and Abstract, Washington, DC, Sept 1987

91. Tseng YC, Burman KD, D’Avis JC, Lahiri S. And Wartofsky L.  Thyrotropin Enhances Epidermal Growth Factor Receptor in Intact Human Thyroid Cells.  Endocrine Society 70th Annual Meeting, New Orleans, LA, June 1988.

92. Ahmann AJ, Tseng YC, Burman KD, Sellitti DF, Wartofsky L. [125I] - Antriopeptin Binding to Cultured Porcine Thyrocytes: Influence of Iodine and Thyrotropin.  70th Annual Meeting Endocrine Society, New Orleans, LA, June 1988.

93. Baker Jr JR., Solomon BL, Saunders NB, Burman KD.  The Failure of Immunotherapy using Intravenous IgG (IVIgG) to Alter the Hyperthyroidism of Graves’ Disease.  Clinical Research 36:382A, 1988.

94. Baker Jr JR., Saunders NB, Burman KD.  A Single Human Monoclonal Antibody Derived from Lymphocytes of a Graves’ Disease (GD) Patient with Activity of TBII, TSI and TGSI.  Clinical Research 36:389A, 1988.

95. Reed HL, Kowalski K, Shakir KM, Burman KD, O’Brian JT, Lewis RB.  Multiple Cold Air Exposures Elevate Serum Total and Low Density Lipoprotein Cholesterol in Euthyroid Men.  Clinical Research 36:389A, 1988.

96. Tseng YL, Schaudies RP, Ahmann A, D’Avis J, Geelhoed GW, Burman KD, Wartofsky L.  Effects of Epidermal Growth Factor (EGF) on Thyroglobulin (TG) and Cyclic AMP Production by Human Thyrocytes in Long-Term Cultures, American Thyroid Association Annual Meeting, Abstract 114, 1988.

97. Burman KD, Djuh YY, Kesler P, Baker JR, D’Avis JC.  Analysis of Epidermal Growth Factor Receptor Gene (ERB-B) in Thyrocytes from Patient with Thyroid Disorders.  70th Annual Meeting Endocrine Society, New Orleans, LA, June 1988.

98. Burman KD, Djuh YY, Kesler P, Baker JR, D’Avis JC.   Analysis of Thyroid Hormone Receptor Gene (c-erb A Beta) in Thyrocytes from Patient with Thyroid Disorders.  Presented at 71st Annual Meeting Endocrine Society, Seattle, WA, June 1989.

99. Baker Jr., JR, Saunder NB, Polly SN, Landry F, Stricker RB, Burman KD.  Identification of Thyroid Histones as Auto-Antigens Using Human Monoclonal Antibodies.  Clinical Research 37:356A, 1989.

100. Polly SN, Saunders NB, Marry K, Stricker RB, Burman KD, Baker Jr., JR.  Evaluation of the Binding characteristics of human Monoclonal Antibodies Directed Against Histones.  Clinical Research 37:588A, 1989.

101. Tseng YL, Lahiri S, Sellitti DF, Burman KD, Wartofsky L.  Atrial Natriuretic Peptide Inhibits Thyroglobulin Secretion from Human Thyroid Cells by Affinity Cross-Linking.  64th Annual Meeting, American Thyroid Association, San Francisco, CA, September 1989.

102. Tseng YL, Sellitti DF, Burman KD, Wartofsky L.  Characterization of a Receptor for Atrial Natriuretic Peptide in Human Thyroid Cells by Affinity Cross-Linking.  64th Annual Meeting, American Thyroid Association, San Francisco, CA, Sept 1989.

103. Baker Jr., JR, Saunders NB, Stricker RB, Burman KD.  Unusual Cytoplasmic Nucleoproteins are Autoantigens in Graves’ Disease (GD).  American Federation Clinical Research, 1989.

104. Fein HG, Burman KD, Djuh YY, Usala SJ, Smallridge RC.  Linkage between the Syndrome of Generalized Thyroid Hormone Resistance (GTHR) and the Human C-erbA Gene is Present in Multiple Kindreds.  American Thyroid Association, San Francisco, CA, Abstract 1, Sept 1989.

105. Burch HB, Lukes YG, Cai WY, Carr FE, Wartofsky L, Burman KD.  A Novel Approach to the Identification of Uniquely Expressed Genes in Graves’ Disease Thyroid Tissue.  Clinical Research 38:264A, 1990.

106. Solomon B, Wartofsky L, Burman KD.  Cholestyramine Treatment of Thyrotoxicosis.  Endocrine Society, Abstract 329, June 1990.

107. Humphrey M, Mosca J, Baker JR, Drabick J, Carr FE, Burke D, Wartofsky L, Burman KD.  Search for Retroviral DNA Sequences in Genomic DNA Isolated from Patients with Graves’ Disease.  Clinical Research 38:383A, 1990.

108. Peele M, Carr FE, Baker JR, Wartofsky L, Burman KD.  Thyrotropin Gene Expression in Human Lymphocytes.  Clinical Research 38:296A, 1990.

109. Hicks KA, Tseng YL, Lahiri S, Burman KD, D’Avis JC, Sellitti D, Wartofsky L. Thyrotropin Augments Internalization of the Atrial Natriuretic Peptide Receptor Complex in Thyrocytes.  Endocrine Society, Abstract 729, June 1990.

110. Burman KD, Djuh YY, Nicholson D, Fein H, Usala S, Bradley WEC, Berard J, Wartofsky L.  Identification of a Unique Mutation in Affected Members of a Family with the Syndrome of Generalized Thyroid Hormone Resistance.  Endocrine Society Meeting, Washington, DC, Abstract 848, June 1991.

111. Nagy E, Burch H, Burman KD.  TSH Reduces PHA Induced Lymphocyte Proliferation In Vitro.  Endocrine Society Meeting, Washington, DC, Abstract 1232, June 1991.

112. Jackson S, Tseng YL, Lahiri S, D’Avis JC, Burman KD, Wartofsky L.  Endothelin and the Thyroid: Tissue Receptors and Clinical Correlates.  Clinical research 39:207A, April 1991. 

113. Nagy E, Burch HB< Lukes YG, Burman KD.  Investigations concerning an Immunogenic Epitope of the Human TSH Receptor.  American Thyroid Association annual Meeting, Boston, MA, Abstract 63, Sept. 1991

114. Burman KD, Lukes YG, Gemski P.  Molecular Homology between the Human TSH Receptor and Yersinia Enterocolitica.  American Thyroid Association Annual Meeting, Boston, MA, Abstract 122, Sept. 1991.

115. Haibach H, Burns TW, Carlson HE, Burman KD, Deftos LJ.  Cowden’s Disease Associated with Merkel Cell Carcinoma and Renal Cell Carcinoma.  Clinical Research 39:704a, October 1991.

116. Nagy EV, Burch HB, Lukes YG, Burman KD.  Lymphocyte Responsiveness to Immunogenic Peptides of the Human TSH Receptor.  Endocrine Society Annual Meeting, Abstract 446, San Antonio, TX, June 1992

117. Soloman B, and Burman KD.  The Prevalence of Bone Fractures in Women with Thyroid Disease.  Endocrine Society Annual Meeting, Abstract 424, San Antonio, TX, June 1992.

118. Coffey L, Burman KD.  Predicting Energy Expenditure Women with Gestational Diabetes Mellitus.  Submitted, March 1992.

119. Nagy EV, Burman KD.  Graves’ IgG Recognizes Linear Epitopes in the Human Thyrotropin Receptor.  American Thyroid Association Annual Meeting, Rochester, MN, September 1992, Abstract 128.

120. Burch HB, Sellitti D, Nagy E, Burman KD.  Immunohistochemical Staining pattern of Human and Porcine Thyroid Cells with Sera Directed Against an Immunogenic Thyrotropin Receptor Peptide.  American Thyroid Association Annual Meeting, Rochester, MN, Abstract 126, Sept. 1992.

121. Burch HB, Barnes S, Sellitti D, Nagy E, Burman KD.  Graves’ Retroocular Fibroblasts Contain Protein Which is Immunogenically Related But not Identical to the Thyrotropin Receptor.  75th Annual Meeting, Endocrine Society, Las Vegas, NV, Abstract 131, 1993.

122. Bhatia SK, Kuppers RC, Ross NR, Saboori AM, Burch HB, Nagy EV, Burman KD.  Thyroglobulin Epitopes Involved in Autoimmune Thyroid Disease.  75th Annual Meeting, Endocrine Society, Las Vegas, NV, Abstract 1279, 1993.

123. Burman KD.  Issues in Management of Thyroid Cancer: Should Radioiodine Scans Still be Performed? Plenary Lecture, Endocrine Society, Las Vegas, NV, 1993.

124. Solomon B, Wartofsky L, Burman KD.  Management of Differentiated Thyroid Carcinoma: Results of a Survey of A.T.A.  Members.  Submitted, American Thyroid Association Annual Meeting, Tampa, FL, Abstract 67, Nov.  1993.

125. Nagy EV, Burch HB, Burman KD.  Unidirectional Shift of the Dominant T Cell Epitope in the Human Thyrotropin Receptor in Graves’ Disease.  Submitted, American Thyroid Association Annual Meeting, Tampa, FL, Abstract 114, Nov. 1993.

126. Kalvaitis S, Burman KD, Pierce L, Buchly M, and Wartofsky L.  Washington Hospital Center, Washington, DC.  Successful treatment of a patient with thyroid storm: combined use of lithium, ipodate, cholestyramine and charcoa hemoperfusion.  April 1995.

127. Atwa MA, Smallridge RC, Gist ID, AboHashem MB, El-Kannishy MB and Burman KD.  Effects of bradykinin and TSH on phospholipase C and A2 systems in Retroocular fibroblasts obtained from patients with Graves’ Ophthalmopathy.  11th International Thyroid Congress, Toronto, Canada, September 10-15, 1995.

128. Ringel T, Taylor CE, Freter L, Diehl R, Howard R, and Burman KD.  Hodgkin’s Disease is associated with increased antibody cellular cytotoxicity against human orbital muscle cells (ADCC).  11th International Thyroid Congress, September 10-15, 1995, Toronto, Canada.

129. Solomon RL, Cranston T, McDermott MT, ASP A, Burman KD.  Treatment of Graves’ Disease with Cholestyramine.  The Endocrine Society, Washington, DC, January 1995.

130. Ringel MD, Carr FE, Nicholson D, and Burman KD.  Endogenous mutant p53 binds p53-specific binding sites and data binding protein in thyroid carcinoma cells.  The Endocrine Society, Washington, DC, January 1995.

131. Burman KD, Atwa M, Kiang JC, Gist ID, Rui L, Lahn R, Smallridge RC.  Evidence for the involvement of protein kinase C (PKC) isoforms in the proliferation of retro ocular fibroblasts (ROF) obtained from patients with Graves’ Ophthalmopathy.  10th International Congress of Endocrinology, Washington, DC, January 1996.

132. Smallridge RC, Porter L, Burman KD, Cranston T, Tsokos GC and Solomon BL.  Soluble interleukin-2 receptor (sIL2R) is an early response marker in the treatment of thyrotoxicosis.  10th International Congress of Endocrinology, Washington, DC, January 1996.

133. Torrens J, Bernet V, Mahoney K, Solomon B, Burman KD, Wartofsky L, Duncan W. Cycle etidronate increases lumbar spine bone mineral density (LS BMD) of women taking Levothyroxine.  10th International Congress of Endocrinology, Washington, DC, January 1996.

134. Kalvaitis S, Burman KD, Perry D, Wartofsky L.  Ret oncogene testing for medullary cancer: a clinically relevant advance.  American College of Physicians, 1996 National Associates Competition, Clinical Vignette Paper Competition Winner, Philadelphia, PA.

135. Tseng Y, Lahiri S, Nicholson D, Burman KD and Wartofsky L.  Evidence of an association of endothelin-1 receptor expression to the active growth phase of the cell cycle and identification of endothelin-1 mRNA in FRTL5 cells.  Endocrinol & Metab, 1996, 3, 37-47.

136. Karl M, Ellahham S, Oskoui R, Wartofsky L and Burman KD.   Thyrotoxicosis associated with rapidly reversible low-output heart failure and dilated cardiomyopathy.  Poster presentation.  79th Annual Meeting of the Endocrine Society, Minneapolis, MN.  June 1997.

137. Lu R, Wartofsky L, Bahn R, Garrity J, Sutton BD and Burman KD.  Role of oxygen free radicals in IL-1B-induced glycosaminoglycan production by retroocular fibroblasts from patients with Graves’ Ophthalmopathy.  Poster presentation.  79th annual Meeting of the Endocrine Society, Minneapolis, MN, June 1997.

138. Rahmaniyan M, Burman, KD, Lando HM.  Occurrence of an invasive papillary thyroid carcinoma in a hyperfunctioning nodule.  Endocrine Society Annual Meeting.  Poster

139. Prendiville S, Burman KD, Ringel MD, Shmookler BM, Deeb ZE, Wolfe K, Azumi N, Wartofsky L, Sessions RB.  Prognostic implications of the tall cell variant of papillary thyroid carcinoma.  Presentation.  Annual meeting of Otolaryngology-Head and Neck Surgery, San Antonio, TX.  September 1998.

140. Lu R, PV Balducci-Silano, Ringel MD, Ress J, Bahn RS, Garrity J, Wartofsky L, Tsokos GC, Burman, KD.  Modulation of Fas/Fas ligand expression in retro ocular fibroblasts from patient with Graves’ Ophthalmopathy.  Poster presentation at the Annual Endocrine Society, pp 3-205, June 1998.

141. Gardner R, Tuttle R, Burman KD, Haddady S, Truman C, Wartofsky L, Sessions R, Ringel M.  Intra thyroidal and extra thyroidal vascular invasion are associated with distant metastasis at diagnosis and tumor recurrence in papillary thyroid carcinoma.  71st annual Meeting of the American Thyroid Association, Abstract 171, September 1998.

142. Ringel M, Balducci-Silano P, Tuttle R, Djuh Y, Anderson J, Burman KD, Wartofsky L, Silverman J, Kazarosyan M, Spencer c, Ladenson P, Levine M.  Quantitative thyroglobulin RT-PCR detection of recurrent or residual thyroid carcinoma in patients with anti-thyroglobulin antibodies.  71st Annual Meeting of the American Thyroid Association, Abstract 169, September 1998.

143. Lu R, Balducci-Silano PL, Ringel MD, Vodovitz Y, Burman KD.  Fas, Fas ligand expression and Fas-medicated apoptosis in human retro ocular fibroblasts.  Endocrine Society Annual Meeting, 1-343, June 1999.

144. Balducci-Silano PL, Lu R, Burman KD, Ringel MD, Thyroid cancer cells express Fas and Fas ligand but are resistant Fas-mediated apoptosis.  Endocrine Society Annual Meeting, 1-589, June 1999.

145. Ringel MD, Balducci-Silano PL, Anderson JS, Spencer CA, Silverman J, Sparling YH, Burman KD, Wartofsky L, Ladenson PW, Levine MA, Tuttle RM.  Clinical evaluation of quantitative thyroglobulin PCR and immunoassay in 107 patients with thyroid cancer.  Endocrine Society Annual Meeting, 2-718, June 1999.

146. Suzuki K, Moriyama E, Mori-Aoki A, Katoh R, Royaux LA, Green RD, Kohn LD, Burman KD.  Pendred syndrome gene, PDS, is an apical porter of iodide and its expression is tightly regulated by follicular thyroglobulin.  Presented at the annual meeting of the American Thyroid Association, September 1999.

147. Greenberg M, Chen X, Hayre N, Suzuki K, Saji M, Priebat D, Burman KD, Ringel MD.  Cytotoxic activity of 2', 2'-difluorodeosycytidine (Gemcitabine) against poorly differentiated human thyroid carcinoma cells.  Endocrine Society, 2000.

148. Ringel MD, Daniels M, Hayre N, Burch H, Bernet V, Savnier B, Shuppert F, Wartofsky L, Burman KD, Kohn LD, Saji M.  Over expression and over activation of AKT in thyroid carcinoma.  Presented at the International Thyroid Congress, Kyoto, Japan October 2000.

149. Ringel MD, Bernet V, Burch H, Schuppert F, Burman KD, Saji M.  Overexpression of a Metastasis Inhibiting Receptor (Metastin Receptor) in Papillary, but not Follicular, Thyroid Carcinoma. American Thyroid Association, November, 2001

150. Ringel MD, Hayre N, Saito J, Saunier B, Schuppert F, Burch H, Bernet V, Burman KD, Kohn LD, Saji M.  Overexpression and Overactivation of Akt in Thyroid Carcinoma.  American Thyroid Association, November 2001.

151. Hayre N, Peck G, Nigra T, Bixby K, Saji M, Burman KD, Ringel MD.  Detection of circulating malignant melanoma cells in peripheral blood by real-time PCR assay.  American Academy of Dermatology, 2001.

152. Chen XW, Saji M, Balducci-Silano P, Hayre N, Spencer CA, Burman KD, Ringel MD.  Recombinant human thyrotropin stimulation of circulating thyroglobulin mrna in patients with thyroid cancer.  American Thyroid Association, November 2001.

153. Miyagi E, Saji M, Burman KD, Singer D, Ringel MD.  Stable expression of Ret/PTC 3 in FRTL-5 thyroid cells enhances basal and insulin-stimulated activation of Akt.  American Thyroid Association November 2001.

154. Vaishnav Y, Anderson J, Adair C, Rheinhardt B, Saji M, Burman KD, Burch H, Ringel MD, Bernet VJ.  Is BAG-1 a useful molecular marker in the differentiation of thyroid cancer from benign thyroid nodules?  American Thyroid Association, November 2001.

155. Otteson T, Burman KD, Ringel MD, Krishnan J. Proto-Oncogene Positivity in Medullary Thyroid Carcinoma, October 2002, Academy of Otolaryngology.

156. Stathatos N, Saji M, Vasko V, Burman KD, Ringel MD. Metastatin activation inhibits migration and growth of thyroid cancer cells in virto. Endocrine Society Annual Meeting, Philadelphia, PA, 2003.

157. Burningham AR, Krishnan, J, Davidson BJ, Ringel MD, Burman KD. Papillary and Follicular Variant of Papillary Carcinoma of the Thyroid:  Initial Presentation and Response to Therapy, October 2004, Academy of Otolaryngology.

158. Stathatos N, Bourdeau I, Saji M, Vasko V, Bauer A, Burman KD, Stratakis C, Ringel MD. Metastatin Receptor (GPR54) Activation inhibits Growth and Migtration of Thyroid Cancer Cells and Increases Expression of Endogenous Akt and Calcineurin Inhibitors. Endocrine Society Presentation, June, 2004, New Orleans, LA.

159. Vasko V, Kato Y, Saji M, Cheng SY, Burman KD, Ringel MD. Selective Activation of Akt in Thyroid Cancers in TR beta pv/pv Mice. Endocrine Society Presentation, June, 2004, New Orleans, LA.

160. Ly T, Bhagati R, Jarrett J, Tran K, Burman KD. Glucocorticoid Induced Osteoporosis:   Implementation of Prophylaxis and Practice Patterns. May 2005, Submitted to American College of Rheumatology.

161. Diez JJ. Iglesias P. Burman KD. Spontaneous normalization of thyrotropin concentrations in patients with subclinical hypothyroidism. Endocrine Society, June 2005.

162. Atkins FB, Van Nostrand D, Kulkarni K, Burman KD, Wartofsky L. The Frequency with which Empiric Amounts of Radioiodine “Over-” or “Under-” treat Patients with Metastatic Well-Differentiated Thyroid Cancer.  J Nucl Med 2005;46:129P.

163. VanNostrand D, Atkins F, Kulkarni K, Burman KD, Wartofsky L. The Utility of Percent 48-Hour Whole body Retention for Modifying Empiric Amounts of I-131 for the Treatment  of  Thyroid Carcinoma. Society of Nuclear Medicine, San Diego, CA 2006.

164. Vasko V, Hodak S, Russell R, Francis G, Saji M, Ringel M, Burman KD. Cancer Cell- Cancer Cell Paracrine Interactions are Important for Thyroid Cancer Invasion. Endocrine Society, June 2006

165. Kantorovich V, Coppotelli G, Krishnan J, Skarulis M, Celi F, Burman KD. Expression of GLUT Transporters in Metastatic Thyroid Cancer and Correlation with PET Scan. Endocrine Society, June 2006

166. Burman KD, Seiboth, VanNostrand D, Wartofsky L, Jonklaas J. Analysis of the Role of PET/MRI Digital Fusion Images in Detection and Management of Recurrent of Persistent Thyroid Cancer. Endocrine Society, June 2006

167. Van Nostrand D, Atkins F, Kulkarni K, Burman KD, and Wartofsky L. The Utility of Percent 48-Hour Whole Body Retention for Modifying Empiric Amounts of I-131 for the Treatment of Thyroid Carcinoma.  J Nucl Med, (abstract). 2006:7(1):324P.

168. Esposito G, Van Nostrand D, Atkins F, Burman KD, Wartofsky L, Kulkarni, K.   Frequency of “Over” And “Under” Treatment with Empiric Dosage of I-131 in Patients with and without Lung Metastasis Secondary to Well-Differentiated Thyroid Cancer J Nucl Med, (abstract) 2006;47(1):238P

169. Vasko V, Bauer A, Patel A, Kinichenko V, Larin A, Saji M, Ringel M, DeMicco C, Hodak S, and Burman KD. Thyroid Cancer Metastases are Associated with Gain of Stem Cell Markers Expression. Endocrine Society, June 2007.

170. Acio E, Van Nostrand D, Moreau S, Seiboth L, Burman KD. The utility of the interpretation of PET-MR simultaneously versus independent of each other in patients with well-differentiated thyroid cancer.  J Nucl Med 2007.

171. Aiken M, Van Nostrand D, Kulkarni K, Garcia C, Acio E, Boyle L, Burman KD. The utility of 123-I scans in the identification of parathyroid adenomas and/or hyperplasia with rapid 99m-Tc sestamibi washout.  J Nucl Med 2007.

172. Bandarul VVN, Van Nostrand D, Burman KD, Wartofsky L. Selecting 131-I dosage (activity)for the ablation and treatment of patients with well-differentiated thyroid cancer. .J Nucl Med 2007.

173. Van Nostrand D, Atkins F, Garcia C, Moreau S, Burman KD, Wartofsky L. Radiopharmacokinetics of radioiodine in the salivary glands after lemon juice: a case report.  J Nucl Med 2007.

174. Van Nostrand D, Aiken M, Atkins F, Esposito G, Moreau S, Garcia C, Acio E, Burman KD, Wartofsky L. The utility of radioiodine whole body scans prior to 131-I ablation in patients with well-differentiated thyroid cancer.  J Nucl Med, 2007.

175. Atkins F, Van Nostrand D, Moreau S, Burman KD, Wartofsky L. Percent 48-hr whole body retention for estimating maximum tolerated activity of 131-I for the treatment of well-differentiated thyroid cancer: The effect of rhTSH stimulation vs thyroid hormone withdrawal on a bi-exponential dosimetry model. J Nucl Med, 2007.

176. Vasko V, Bauer A, Patel A, Kinichenko V, Larin A, Saji M, Ringel MD, Garcia S, DeMicco, Hodak S, Burman KD. Thyroid Cancer metastases are associated with gain of stem cell marker expression. Endocrine Society, Toronto, Canada, June, 07.

177. Aiken M, Shin Y-R, Kulkarni K, Van Nostrand D, Burman KD; Wartofsky L. Quantitating the superiority of pinhole relative to parallel hole collimator images in detecting foci of radioiodine uptake in the thyroid bed/neck in patients with well-differentiated thyroid cancer. 55th Society of Nuclear Medicine Annual Meeting, New Orleans, LA, June 2008.

178. Wells KJ, Moreau S, Shin YR, Van Nostrand D, Burman KD, Wartofsky L. Predictive factors for and the frequency of positive (+) post-treatment (tx) scans after the radioiodine (RAI) tx of patients with well-differentiated thyroid cancer (WDTC), positive serum throglobulin levels (TG+), and negative diagnostic (dx) RAI whole body scans (WBS-). Society of Nuclear Medicine, June 2008.

179. Wells KJ, Moreau S, Shin, YR, Aiken M, Van Nostrand, D, Burman, KD, Wartofsky L. To treat or not to treat “thyroglobulin-positive and radioiodine diagnostic whole body scan negative” patients with well-differentiated thyroid cancer: an educational exhibit. Society of Nuclear Medicine, June 2008.

180. Bandaru VV, Shin Y-R, Van Nostrand D, Burman KD, Wartofsky L. The prognostic significance of pulmonary findings on diagnostic imaging modalites in patients with pulmonary metastases secondary to well-differentiated thyroid cancer: An educational exhibit. Society of Nuclear Medicine, June 2008.

181. Shin YR, Bandaru V, Van Nostrand D, Moreau S, Burman KD, Wartofsky L. The frequency of heterogeneous uptake and/or hypofunctioning areas on thyroid scintigraphy in patients with Graves' Disease. Society of Nuclear Medicine, June 2008.

182. Shin YR, Kulkarni K, Aiken M, Bandaru V, Wells K, Boyle L, Burman KD, Van Nostrand D. The utility of 123-I subtraction scan (S-scan) combined with dual-time-point (DTP) 99m-Tc sestamibi (MIBI) scan in the identification of parathyroid adenomas (PA) and/or hyperplasia (PH) that were negative or indeterminate on DTP MIBI scan alone. Society of Nuclear Medicine, June 2008.

183. Van Nostrand D, Moreau S, Atkins F, Shin YR, Burman KD, Wartofsky L. I-124 versus I-131 in the identification of suspected residual thyroid tissue or metastasis in patients with well-differentiated thyroid cancer (WDTC). Society of Nuclear Medicine, June 2008.

184. FB Atkins, Van Nostrand D, Butler C, OComparison of the blood biokinetics of I-124 and I-131 in patients with well-differentiated thyroid cancer (WDTC). Society of Nuclear Medicine, June 2008.

185. Manes RP, Wartofsky L, Stathatos NA, Burman KD, Deeb ZE, Chia SH. Thyroglossal Duct Carcinoma, ENT Meeting, 2008

186. Harwick M, Burman KD. Analysis of the Translocator Protein (TSPO) in Thyroid Cancer Cell Lines. American Thyroid Association Meeting, Chicago, IL, October, 2008.

187. Loh JA, Wartofsky L, Jonklaas J, Burman KD. Levothyroxine therapy during pregnancy. Endocrine Society, San Francisco, CA. June, 08.

188. Nadkarni PJ, Burman KD. Propylthiouracil-Induced Fulminant Hepatic Failure.

Endocrine Society, San Francisco, CA. June, 08.

189. G. Khorjekar, D. Van Nostrand, A. Acio, S. Chennupati, K. Prasad, K. Kulkarni, K. Burman. Locations and patterns of frequent, infrequent, and rare sites of metastasis secondary to well-differentiated thyroid cancer. Society of Nuclear Medicine 2010.

190. G. Khorjekar, D. Van Nostrand, S. Moreau, F. Atkins, M. Mete, K. Burman, L Wartofsky. Survival rate in patients diagnosed with well-differentiated thyroid cancer with bone metastases the Washington Hospital Center Experience. Society of Nuclear Medicine 2010.

191. G. Khorjekar, D. Van Nostrand, K. Kulkarni, C. Garcia, S. Moreau, A. Ansari, K. Prasad, K. Burman. Pilot study assessing actors altering radioiodine uptake in breast tissue in patients with well-differentiated thyroid cancer. Society of Nuclear Medicine 2010..

192. Burman, K. The frequency of parathyroid adenomas and/or hyperplasia that have washout equal to normal thyroid tissue in patients who have a negative dual-time-point 99m-Tc sestamibi scans. Society of Nuclear Medicine 2010.

193. Iyengar, K., Burman, K. Utility of Low Concentrations of Serum Thyroglobulin in Predicting Residual or Recurrent Disease in Patients Treated for Well-differentiated Thyroid Cancer. Endocrine Society, Annual Meeting, San Diego, CA.

194. Klubo-Gwiezdzinska, J, Burman, K,Van Nostrand, D, Wartofsky, L. An undetectable initial rhTSH-stimulated Tg levels 12 months after the initial treatment of thyroid cancer serves as a good but not infallible indicator for cure. Endocrine Society, Annual Meeting, San Diego, CA.

195. Singla, S, Gogineni, J, Wartofsky, L, Burman, K. Prediction of Malignancy In Nodular Thyroid Disease by Serum Thyroglobulin (Tg) Measurement. Endocrine Society, Annual Meeting, San Diego, CA 2010.

196. Wartofsky, L, Burman, K. An undetectable initial rhTSH-stimulated Tg levels 12 months after the initial treatment of thyroid cancer serves as a good but not infallible indicator for cure. Endocrine Society, San Diego, CA 2010Jonklaas, J, Burman, K. Age and the TSH Response to Hypothyroxinemia and Recombinant Thyrotropin. Endocrine Society, Annual Meeting, San Diego, CA 2010.

197. Kureti V, Burman K, Wexler J. Graves’ disease complicated by paralysis and anterior mediastinal mass. National ACP Toronto, Canada.

198. Reutemann, P, Ogram, A, Burman, K, Lockshin, B, Dugan, E. A Solitary Cutaneous Metastasis from Papillary Thyroid Adenocarcinoma. American Academy of Dermatology, August 2010.

199. Khorjekar G1, Van Nostrand D1, Kharazi P1,  Moreau S1, Atkins F1, Chennupati S1, Mete M4, Burman K2, Wartofsky L. 124I PET versus 131I planar imaging in the identification of functioning residual thyroid tissue and/or metastases in patients with differentiated thyroid cancer: Update of Initial report. submitted to Society of Nuclear Medicine annual meeting, 2010.

200. Klubo-Gwiezdzinska J, Costello J, Jr, Jensen K, Burman KD, Wartofsky L, Vasko VV. Metformin Activates AMPK and Inhibits Thyroid Cancer Cell Growth in an Oncogene-Specific Manner. Endocrine Society, Annual Meeting, Boston, MA 2011.

201. Klubo-Gwiezdzinska J, Burman KD, Van Nostrand D, Mete M, Wartofsky L. Preparation with Recombinant Human Thyrotropin (rhTSH) Stimulation or Levothyroxine (T4) Withdrawal for Radioiodine (RAI) Treatment Gives Comparable Results in Patients with Metastatic Differentiated Thyroid Cancer (DTC). Endocrine Society, Annual Meeting, Boston, MA 2011.

202. Klubo-Gwiezdzinska J, Burman KD. Metformin Inhibits Anaplastic Thyroid Cancer Cells Growth through AMPK-dependent Down-regulation of mTOR/6SK Signaling. 81st Annual Meeting of the American Thyroid Association, Indian Wells, CA October 2011.

203. Sathasivam A, Shapiro S, Pehlivanova M, Rapaport R, Burman K. Factors Associated with a Pubertal Response to Leuprolide Stimulation in Females with Suspected Central Precocious Puberty. Endocrine Society poster presentation at ENDO 2011, June 2011 Boston, MA.

204. Khorjekar G, Burman K. The relationship of 123I breast uptake on thyroid scan to thyroid stimulating immunoglobulin in hyperthyroid patients:  A pilot study Submited January 2011.

205. Burman K. Does Lemon Juice Increase Radioiodine Re-Accumulation within the Parotid Glands Greater Than If Lemon Juice Had Not Been Administered? Submitted to Annual Meeting Society of Nuclear Medicine, 2011.

206. Schneider MT, Garcia C, O’Neil J, Van Nostrand D, Wexler J, Burman K, Wartofsky L.  Retrospective Study of the Utility of 18F Sodium Fluoride PET Bone Scans in Patients with Thyroid Cancer. Submitted to the SNM Annual Meeting, held June 2012, Miami, FL

207. Khorjekar G, Burman K. Does a negative diagnostic 131I planar scan AND 124I PET scan in patients with elevated Tg exclude 131I uptake on 131I post- therapy scan? Updated Results, submitted to the SNM Annual Meeting, held June 2012, Miami, FL

208. Klubo-Gwiezdzinska J, Jensen K, Costello Jr J, Patel A, Bauer A, Burman K, Wartofsky L, and Vasko V. Metformin Inhibits Growth and Decrease Resistance to Anoikis in Medullary Thyroid Cancer Cells. The Endocrine Society 2012

209. Khorjekar G, Burman K. Does a negative diagnostic 131I planar scan AND 124I PET scan in patients with elevated Tg exclude 131I uptake on 131I post- therapy scan? Updated Results, SNM Annual Meeting, held June 2012, Miami, FL

210. Klubo-Gwiezdzinska J, Jensen K, Costello Jr J, Patel A, Bauer A, Burman K, Wartofsky L, and Vasko V. Metformin Inhibits Growth and Decrease Resistance to Anoikis in Medullary Thyroid Cancer Cells. The Endocrine Society 2012.

211. Kushchayeva Y, Costello J, Carroll N, Boyle L, Burman K, Vasko V. Nelfinavir, a HIV protease inhibitor, induces growth arrest and apoptosis in medullary thyroid cancer cells via inhibition of RET kinase signaling. Presentation at International Thyroid Oncology Group. May 2013.

212. Kushchayeva Y, Kushchayev S, Caroll N, Felger E, Burman K, Boyle L. Spinal Metastases Secondary to Follicular (FTC) and Papillary (PTC) Thyroid Carcinomas: A Comparative Analysis of 174 cases. Presentation at International Thyroid Oncology Group. May 2013.

213. Klubo-Gwiezdzinska J, John Costello, Jr, Aneeta Patel, Andrew Jacob Bauer, Kirk Ernest Jensen, Mihriye Mete, Kenneth Burman and Leonard Wartofsky. Treatment with Metformin is Associated with Higher Remission Rate in Diabetic Patients with Thyroid Cancer. Endocrine Society, San Francisco, CA. June, 2013.

214. Popoveniuc G, Tanu Chandra, Meeta B Sharma, Marc R Blackman, Kenneth Burman and Leonard Wartofsky. Establishment of a Diagnostic Scoring System for Patients with Myxedema Coma. Endocrine Society, San Francisco, CA. June, 2013.

215. Popoveniuc G, Kenneth Burman, Jacqueline Jonklaas, Uha Prabhakar Reddy and Shannon Danielle Sullivan. Comparison of empiric versus individualized levothyroxine (LT4) dose adjustment in hypothyroid women during pregnancy: interim data analysis. Endocrine Society, San Francisco, CA. June, 2013.

216. Kushchayeva Y John Costello, Erin Felger, Lisa Boyle, Kenneth Burman and Vasyl Vasko. The HIV protease inhibitor Nelfinavir down-regulates p70S6K/S6 signaling, induce autophagy and apoptosis in thyroid cancer cells. Endocrine Society, San Francisco, CA. June, 2013.Brackbill AJ, Kenneth Burman, David S Cooper and Henry B Burch.
     The Effect of Geographical Location in the United States on the Management of Graves' Disease Endocrine Society, San Francisco, CA. June, 2013.

217. Jonklaas J, Sathasivam1 A,  Wang H, Finigan D, Gu J,  Soldin OP, Burman KD,  Soldin S. Thyroid hormone measurements: Discrepancies between mass spectrometry and immunoassay. American Thyroid Association Annual Meeting, San Juan, Puerto Rico. October 2013.

218. Choudary C, Burman KD. Thyroid bed nodules on ultrasonography. American Thyroid Association Annual Meeting, San Juan, Puerto Rico. October 2013.

219. Soldin OP, Melvin C, Burman KD, Younis I. Unique studies of levothyroxine pharmacokinetics in the elderly. American Thyroid Association Annual Meeting, San Juan, Puerto Rico. October 2013.

220. Kuschchayeva Y, Kuschchayeva S, Carroll N, Felger E, Burman KD, Boyle L. Comparative analysis of follicular and papillary thyroid carcinoma spinal metastases. American Thyroid Association Annual Meeting, San Juan, Puerto Rico. October 2013.

221. Bikas A, Jensen K, Costello J, Patel A, Burman K and Vasko V. Expression of Organic Cation Transporter 1 (OCT1) in Medullary Thyroid Cancer. Presented, 84th Annual Meeting of the American Thyroid Association, San Diego, CA. November, 2014.

222. Bikas A, Burman K, Desale S, Mete M, Wartofsky L, Van Nostrand D. Effects of Dosimetry-Guided 131I Therapy for Metastatic Differentiated Thyroid Cancer on Complete Blood Counts. Presentation 97th Annual Meeting The Endocrine Society. March, 2015.

223. Bikas A, Jensen K, Costello J, Patel A, Burman K and V. Vasko. Glucose Concentration Underlies the Efficacy of Treatment with Metformin in Thyroid Cancer Cells. Presentation (97th Annual Meeting of the Endocrine Society. San Diego. March, 2015.

224. Bikas A, Van Nostrand D, Jensen K, Desale S, Mete M, Wartofsky L, Vasko V, Burman K. Metformin Attenuates 131I – Induced Decrease in Peripheral Blood Cells in Patients with Differentiated Thyroid Cancer. Society of Nuclear Medicine and Molecular Imaging Annual Meeting. Baltimore, MD. 2015.

225. Bethancourt E, Van Nostrand D, Orquiza M, Bloom G, Bikas A, Burman K, Wartofsky L. The public sites and the frequency of detection of patients treated with I-131 and the security management of those patients: the final report of a national survey. Society of Nuclear Medicine and Molecular Imaging Annual Meeting. Baltimore, MD. 2015.

226. Bethancourt E, Van Nostrand D, Orquiza M, Bloom G, Bikas A, Burman K, Wartofsky L. The frequency and content of documents issued for patients’ 131I therapies for security agents: the final report of a national survey. Society of Nuclear Medicine and Molecular Imaging Annual Meeting. Baltimore, MD. 2015.

227. A. Bikas, P. Kundra, J. Wexler, M.Mete, S. Desale, L. Wray, C. Barett, B. Clark, L. Wartofsky, K. Burman. Phase II Clinical Trial of Sunitinib as Adjunctive Treatment in Patients with Advanced Differentiated Thyroid Cancer. 97th Annual Meeting of the Endocrine Society. March, 2015.

228. E. Bethancourt, D. Van Nostrand, M. Orquiza, G. Bloom, A. Bikas, K. Burman, L. Wartofsky. The public sites and the frequency of detection of patients treated with I-131 and the security management of those patients: the final report of a national survey. Presented at the Society of Nuclear Medicine and Molecular Imaging Annual Meeting (SNMMI 2015 – Baltimore, MD – 6/2015)

229. Bethancourt, D. Van Nostrand, M. Orquiza, G. Bloom, A. Bikas, K. Burman, L. Wartofsky. The frequency and content of documents issued for patients’ 131I therapies for security agents: the final report of a national survey. Presented at the Society of Nuclear Medicine and Molecular Imaging Annual Meeting (SNMMI 2015 – Baltimore, MD – 6/2015)

230. A.Bikas, K. Jensen, J. Costello, A. Patel, L. Wartofsky, K. Burman, V. Vasko. The Oncotic Death Pathway in Thyroid Cancer Cells. Presented at the 15th International Thyroid Congress (Orlando, FL – 10/2015)

231. I. Singh, A. Bikas, C. Garcia, D. Van Nostrand, S. Desale, L. Wartofsky, K. Burman. Relation between 18FDG-PET SUV and size of lesions in thyroid carcinoma. Presented at the 15th International Thyroid Congress (Orlando, FL – 10/2015)

232. K. Jensen, A.Bikas, J. Costello, A. Patel, K. Burman, V. Vasko. Inhibition of mitochondrial complex 4 increases glucose consumption in thyroid cancer cells. Presented at the 15th International Thyroid Congress (Orlando, FL – 10/2015)

233. Y. Kuschayeva, K. Jensen, A.Bikas, J. Costello, A. Patel, K. Burman, V. Vasko. The Role of Autophagy in Thyroid Cancer Cells Response to the Treatment with HIV Protease Inhibitor Nelfinavir. Presented at the 15th International Thyroid Congress (Orlando, FL – 10/2015)

234. A.Bikas, A. Boulougoura, F. Mirza, S. Vachhani, L. Wartofsky, D. Van Nostrand, K Burman. The Metabolic Profile Post a Dosimetry-Guided I-131 Therapy in Patients with Metastatic Differentiated Thyroid Cancer. Will be presented at the 98th Annual Meeting of the Endocrine Society – ENDO 2016 (Boston, MA – 4/2016)

235. A.Bikas, K. Jensen, A. Patel, J. Costello, L. Wartofsky, K. Burman, V. Vasko. High Glucose Decreases the Anti-Neoplastic Efficacy of Metformin in Medullary Thyroid Cancer Cells. Will be presented at the 98th Annual Meeting of the Endocrine Society – ENDO 2016 (Boston, MA – 4/2016)

236. Bikas A, Jensen K, Patel A, Costello J, Tkave R, Wartofsky L, Burman KD, Vasko V. The Role of Autophagy Regulator LC3B in Thyroid Cancer Cells Response to Metabolic Stress and Radiation. Poster 310. American Thyroid Association Annual Meeting, Denver, CO. March, 2016.

237. Parikh T, Shmouni FH, Burman KD, Carroll N. Sharma M, Sidhu, S. Spontaneous Intrathyroidal Hemorrhage Precipitated by Anticoagulation Therapy Resulting in Acute Respiratory Failure. Poster 251. American Thyroid Association Annual Meeting, Denver, CO. March, 2016.

238. A. Bikas, K. Jensen, J. Costello, A. Patel, K. Burman and V. Vasko Mitotane induces mitochondrial membrane depolarization and apoptosis in thyroid cancer cells. Endocrine Society Meeting, Apr. 2017.

239. Gomes-Lima CJ, Nikiforov YE, Burman KD. Two Different Mutations in Coexistent Papillary Thyroid Carcinoma in Both Struma Ovarii and in the Thyroid Gland. Invited to compete in the Endocrine Society’s Presidential Poster Competition for a first-authored top-scoring abstract for presentation at the Annual Meeting & Expo. Endocrine Society 99th Annual Meeting, Orlando, FL, 2017.

240. Wu D, Turner D, Burman K, Wartofsky L, Van Nostrand D. Checklist of criteria for the systematic assessment of patient-management guideline development. Journal of Nuclear Medicine. SNMMI 2017 Annual Meeting, Denver, CO.

241. Wu D, Lima CJ, Turner D, Burman K, Van Nostrand D. Radioiodine refractory differentiated thyroid cancer classifications and evolution. SNMMI 2017 Annual Meeting, Denver, CO.

242. Wu D, Turner D, Burman K, Wartofsky L, Van Nostrand D. Checklist of criteria for the systematic assessment of patient-management guideline development. Featured Poster for Poster Competition. SNMMI 2017 Annual Meeting, Denver, CO.

243. Wu D, Gomes Lima C, Moreau S, Kulkarni K, Zeymo A, Burman K, Wartofsky L, Van Nostrand D. Overall survival rate of patients with differentiated thyroid cancer bone metastasis. 3rd World Congress on Thyroid Cancer, Boston, MA, 2017.

244. Wu D, Turner D, Orquiza M, Burman K, Wartofsky L, Van Nostrand D. Sialoadenitis and xerostomia secondary to I-131 therapy in patients with differentiated thyroid cancer and who took sialagogues: a prospective study. 3rd World Congress on Thyroid Cancer, Boston, MA, 2017.

245. Costello J, Klubo-Gwiezdzinska J, Bikas A, Burman KD, Vasko V. Digital PCR is a powerful technique to detect BRAF mutation in patients with thyroid cancer. 87th Annual American Thyroid Association, October 2017, Victoria, Canada.

246. Turner D, Wu D, Burman KD, Wartofsky L, Van Nostrand D. Low-iodine diet and urine iodine measurements for 131-I tretments in patients with differentiated thyroid cancer: A comparison of 18 clinical practice guidelines. 87th Annual American Thyroid Association, October 2017, Victoria, Canada.

247. Kleess L, Kadambi P, Burman KD. An uncommon case of Cowden syndrome. 87th Annual American Thyroid Association, October 2017, Victoria, Canada.

248. Gomes-Lima CJ, Wu D, Hritani R, Punukollu S, Rao S, Zeymo A, Deeb H, Mete D, Van Nostrand D, Jonklaas J, Burman KD. Brain metastases from differentiated thyroid carcinoma: Current therapies and outcomes. 87th Annual American Thyroid Association, October 2017, Victoria, Canada.

249. Luo H, Tobey A, Auh S, Cochran C, Zemskova M, Gomes Lima CJ, Van Nostrand D, Burman KD, Wartofsky L, Van Nostrand D. Pretreatment with Lithium may be associated with improved overall survival in patients undergoing dosimetry-based radioactive iodine treatment for metastatic differentiated thyroid carcinoma. 87th Annual American Thyroid Association, October 2017, Victoria, Canada.

250. Wu D, Gomes Lima C, Moreau S, Kulkarni K, Zeymo A, Burman KD, Wartofsky L, Van Nostrand D.  Prognostic factors in the overall survival rate of patients with differentiated thyroid cancer bone metastases. 87th Annual American Thyroid Association, October 2017, Victoria, Canada.

251. Wu D, Khorjekar G, Kharazi P, Zeymo A, Burman KD, Wartofsky L, Van Nostrand D. Xerophthalmia and epiphora secondary to 131-I therapy in patients with differentiated thyroid cancer: A prospective study. 87th Annual American Thyroid Association, October 2017, Victoria, Canada.

252. Burman KD. Controversies in Radioactive Iodine Adjuvant Therapy: Which patients? How much to give? Lecture at the Endocrine Society 100th Annual Meeting, Chicago, IL, 2018.

253. Patel A, Jensen KE, Mendonca-Torres M, Costello J, Hoperia V, Thakur S, Klubo-Gwiezdzinska J, Bikas A, Burman KD, Vasko VV. Targeting cytochrome C oxidase subunit 4 (COX4) inhibits growth and induces apoptosis in medullary thyroid cancer cells. Endocrine Society 100th Annual Meeting, Chicago, IL, 2018.

254. Gomes-Lima C, Chittimoju S, Wehbeh L, Jat SK, Pagadala P, Jhawar S, Al-Jundi MN, Zeymo A, Mete M, Klubo-Gwiezdzinska J, Van Nostrand D, Jonklaas J, Wartofsky L, Burman KD. Radioiodine treatment of metastatic thyroid cancer: progression free survival is similar for patients with distant metastases prepared with either recombinant human TSH or with thyroid hormone withdrawal. Endocrine Society 100th Annual Meeting, Chicago, IL, 2018.

255. Lima CJ, Wu D, Turner D, Burman K, Van Nostrand D. Enhancing Techniques for Radioiodine Imaging of Differentiated Thyroid Cancer. Journal of Nuclear Medicine. 2018 May 1;59(supplement 1):1193-. SNMMI 2018 Annual Meeting, Philadelphia, PA.

256. Wu D, Ylli D, Lima CJ, Lee W, Burman K, Wartofsky L, Van Nostrand D. New use for an old isotope. Journal of Nuclear Medicine. 2018 May 1;59(supplement 1):1338-. SNMMI 2018 Annual Meeting, Philadelphia, PA.

257. Wu D, Heimlich L, Burman K, Wartofsky L, Van Nostrand D. The diagnostic value of 124I PET compared to 131I imaging in differentiated thyroid cancer: systematic review and meta-analysis. Journal of Nuclear Medicine. 2018 May 1;59(supplement 1):1334-.

258. Wu D, Kulkarni K, Garcia C, Burman K, Wartofsky L, Van Nostrand D. Optimal time for 124I PET/CT imaging in metastatic differentiated thyroid cancer. Journal of Nuclear Medicine. 2018 May 1;59(supplement 1):240-.

259. Wu D, Khorjekar G, Kharazi P, Moreau S, Kulkarni K, Burman K, Wartofsky L, Van Nostrand D. Poor compliance for continuous sialogogues in patient-reported surveys. Journal of Nuclear Medicine. 2018 May 1;59(supplement 1):1619-.

260. Shobab L, Gomes-Lima C, Jonklaas J, Wartofsky L, Zeymo A, Burman KD. Clinical, Pathological and Molecular Profiling of Radioactive Iodine Refractory Differentiated Thyroid Cancer. 88th Annual Meeting of the American Thyroid Association, Washington, DC, 2018.

261. Shobab L, Patel A, Costello J, Mendonca-Torres MF, Jensen K, Burman KD, Wartofsky L, Vasko V. Sex-specific expression of the histone lysine-specific demethylases in normal thyroid and thyroid cancer. 88th Annual Meeting of the American Thyroid Association, Washington, DC, 2018.

262. Wu D, Bloom G, Burman KD, Wartofsky L, Van Nostrand D. Nationwide survey on the changes in release of I-131 therapy patients after the implementation of the 2011 NRC regulatory policy. 88th Annual Meeting of the American Thyroid Association, Washington, DC, 2018.

263. Patel A, Costello J, Ylli D, Wartofsky L, Burman KD, Vasko V, Jensen K. Targeted next-generation-sequencing for analysis of oncogenic mutations in medullary thyroid cancers. 88th Annual Meeting of the American Thyroid Association, Washington, DC, 2018.

264. Ylli D, Jensen KE, Costello J, Patel A, Hoperia V, Wartofsky L, Burman KD, Vasko V. Viral- 88th Annual Meeting of the American Thyroid Association, Washington, DC, 2018.

265. Gomes-Lima CJ, Auh S, Thakur S, Zemskova M, Cochran C, Merkel R, Filie A, Raffeld M, Patel S, Xi L, Burman KD, Klubo-Gwiezdzinska J. A Novel Risk Stratification System for Thyroid Nodules with Indeterminate Cytology: A Pilot Cohort Study. Endocrine Society 101st Annual Meeting, New Orleans, LA, 2019. Oral Presentation.

266. Avadhanula SA, Introne W, Soldin S, Stolze B, Regier DS, Ciccone C, Hannah-Shmouni F, Filie A, Burman KD, Klubo-Gwiezdzinska J. High Prevalence of Primary Hypothyroidism in Patients with Alkaptonuria Eighteen Years of Experience. Endocrine Society 101st Annual Meeting, New Orleans, LA, 2019. Oral Presentation.

267. Ylli D, Lima C, Wu D, Gitterman AL, Fernandez SJ, Mete M, Burman KD, Wartofsky L. Immediate Cause of Death in Patients with Thyroid Cancer Progression. Endocrine Society 101st Annual Meeting, New Orleans, LA, 2019.

268. Ylli D, Patel A, Jensen KE, Mendonca-Torres MC, Wartofsky L, Burman KD, Vasko V. Quantitative Assessment of BRAF Mutations in Thyroid Cancer Using Droplet Digital PCR. Endocrine Society 101st Annual Meeting, New Orleans, LA, 2019.

269. Shobab L, Wartofsky L, Jonklaas J, Vasko V, Jensen KE, Zeymo A, Burman KD. Sex-Bias in Clinicopathological Presentation of Patients with Differentiated Thyroid Cancer. Endocrine Society 101st Annual Meeting, New Orleans, LA, 2019.

270. Wu D, Mittra E, Tulchinsky M, Avram A, Ahuja S, Greenspan B, Lima CJ, Ylli D, Burman K, Wartofsky L, Van Nostrand D. Radioiodine dosimetry practices in the United States for differentiated thyroid cancer: preliminary report. Journal of Nuclear Medicine. 2019 May 1;60(supplement 1):1526- SNMMI 2019 Annual Meeting, Anaheim, CA.

271. Wu D, Bloom G, Burman K, Wartofsky L, Van Nostrand D. Nationwide survey on the release of 131I therapy patients to locations other than private residences. Journal of Nuclear Medicine. 2019 May 1;60(supplement 1):1090- SNMMI 2019 Annual Meeting, Anaheim, CA.

272. Gomes-Lima C, Shobab L, Wu D, Ylli D, Avadhanula S, Parikh T, Bikas A, Chittimoju S, McCoy M, Feldman R, Lee W, Rao SN, Wexler J, Jonklaas J, Wartofsky L, Burman K. Do Molecular Profiles of Primary versus Metastatic Radioiodine Refractory Differentiated Thyroid Cancer Differ? 89th Annual Meeting of the American Thyroid Association, Chicago, IL, 2019. Highlighted Oral Presentation

273. Shobab L, Lee W, Carroll N, Felger E, Rosen J, Jonklaas J, Gomes-Lima C, Zeymo A, Belkaid Y, Brenchley J, Wartofsky L, Burman K. Sex-Specific Immune Landscape of Normal and Malignant Thyroid. 89th Annual Meeting of the American Thyroid Association, Chicago, IL,2019.

274. Bikas A, Reinolds S, Mendonca-Torres M, Patel A, Jensen K, Wartofsky L, Burman KD, Vasko V.   Chlorpromazine Inhibits Mitochondrial Functions, Induces DNA Damage and Inhibits Medullary Thyroid Cancer Cell Growth in vitro and in vivo.  9oth Annual Meeting, American Thyroid Association, 2021. 

275. Zheng H, Lai V, Lu J, Kang JK, Shobab L, Felger EA, Carroll NM, Burman KD, Wartofsky L, Rosen JE.  Black Race and   Female Gender were Independent Protective Factors for Thyroid Cancer.  Presented at 90th Annual Meeting, American Thyroid Association, 2021.Annual Meeting of the American Association of Endocrine Surgeons, April 2021

276. Zheng H,  Lai V, Lu J, Kang JK, Shobab L, Desale S, Burman KD,  Wartofsky L, Rosen JE.Multivariate Analysis of Clinical Factors Predictive of Thyroid Cancer Risk.  Presented at 90th Annual Meeting, American Thyroid Association, 2021. 

277. Zheng H, Lai V, Lu J, Kang JK, Felger EA, Carroll NM, Burman KD, Wartofsky L, Rosen JE. Predictive Value of Bethesda Classification and Race on the Aggressive Behaviors of Thyroid Cancer, Presented at 90th Annual Meeting, American Thyroid Association, 2021. 

278. Shobab L, Kumari S, Zheng H, Patel A, Mendonca-Torres M, Jensen K, Klubo-Gwiezdzinska J, Burman KD, Wartofsky L, Vasko V.  Development of benign and malignant thyroid tumors is associated with aberrant expression of the histone lysine-specific demethylases.  Presented at 90th Annual Meeting, American Thyroid Association, 2021. 

279. Zheng H, Lai V, Lu J, Kang JK, Shobab L, Felger EA, Carroll NM, Burman KD, Wartofsky L, Rosen J.  Multivariate Analyses of Clinical Factors Predictive of Lymph Node Metastasis in Thyroid Cancer patients.  Presented at Annual Meeting of the Southern Surgical Association, September 2021. 

280. Zheng H, Lai V, Lu J, Kang JK, Shobab L, Felger EA, Carroll NM, Burman KD, Wartofsky L, Rosen J.   Black race and female gender were Independent Protective Factors for Thyroid Cancer.  Presented at 90th Annual Meeting, American Thyroid Association, 2021. 

ARTICLES / PUBLICATIONS:

1. Burman KD, Cunningham EJ, Klachko DM, Burns TW.  Successful Treatment of Insulin Resistance with Dealinated Pork Insulin.  Missouri Medicine 363-366, June 1973.

2. Burman KD, Cunnigham EF, Klachko DM, Bassoui WE, Burns TW.   Factitious Hypoglycemia.  American Journal of the Medical Sciences 266:23-32, 1973. 

3. Burman KD, Broughton RE, Pflaum WK, Wartofsky L.  Deiodination of 131I Labeled Thyroxine in the Fetal Rat.  Proceedings Society Experimental Biology and Medicine 143:1000-1007, 1973.

4. Burman KD, Warkel R, Wartofsky L.  Solitary Autonomous Thyroid Nodules that Become “Cold.”  D.C. Annals of medicine 42:541-544, 1973.

5. Burman KD, Johnson MS, Earll JM, Wartofsky L.  Clinical Observations on the Solitary Autonomous Thyroid Nodule.  Achieves Internal Medicine 134:915-919, 1974.

6. Luzecky MH, Burman KD, Schulttz ER.  The Syndrome of Inappropriate Secretion of Antidiuretic  Hormone Due to Amitriptylene.  Southern Medical Journal 67:495-497, 1974.

7. Burman, KD, Solitary Autonomous Thyroid Nodules.  Postgraduate Medicine 56:70-74, 1974.

8. Burman KD, Adler RA, Wartofsky L.  Hemiagenesis of the Thyroid Gland.  American    Journal of Medicine 58:143-146, 1975.

9. Burman KD.  What’s New for Diabetes.  Medical time 103:123-138, 1975.

10. Burman KD, Wright FD, Earll JM, Wartofsky L.  Evaluation of a Rapid and Simple Technique for   the Radioimmunoassay of Triiodothyronine.  J Nucl Med 16:662-665, 1975.

11. Burman KD, Dimond RC, Noel GN, Earll JM, Frantz AG, Wartofsky L.  Klinefelter’s Syndrome: Examination of Thyroid Function and TSH and PRL Responses to Thyrotropin Releasing Hormone Prior to and After Testosterone Administration.  J Clin Endocrinol Metab 41:1161-1166, 1975. 

12. Burman KD, Yeager H, Briggs W, Wartofsky L.  Resin Hemoperfusion: A Potential New  Treatment for Thyroid Storm.  Thyroid Research, 1975.  Excerpta Medica, Amsterdam, 437-440, 1976.

13. Burman KD, Dimond RC, Earll JM, Wright FD, Wartofsky L.  Sensitivity to Lithium in Treated Graves’ Disease: Effects on T3, T4, and Reverse T3.  J Clin Endocrinol Metab 43:606-613, 1976.

14. Burman KD, Yeager H, Briggs E, Wartofsky L.  Resin Hemoperfusion: A Method of Removing   Circulating Hormones.  J Clin Endocrinol Metab 42:70-78, 1976.

15. Burman KD, Monchik J, Earll JM, Wartofsky L.  Total and Ionized Calcium and Parathyroid  Hormone in Hyperthyroidism.  Ann Int Med 84:668-671, 1976.

16. Burman KD, Read J, Dimond RC, Strum D, Wright FD, Patow W, Earll JM, Wartofsky L.  Thyroid Hormone Parameters in Human Amniotic Fluid and in Cord and Maternal Serum L Measurements of 3, 3'5'-L-triiodothyronine (Reverse T3), 3,3'-Ldiiodothyronine (3-3'T2) 3,5,3"-triiodothyronine (T3), Thyroxine (T4), Dialyzable T3 and T4, Thyroxine Binding Globulin (TBG), and Total Iodine.  J Clin Endocrinol Metab 43:1351-1359, 1976.

16.   Wartofsky L, Burman KD, Dimond RC, Noel GL, Frantz AG, Earll JM.  Studies on the Nature of Thyroidal Suppression During Acute Falciparum Malaria: Integrity of Pituitary Response to TRH and Alterations in the Conversion of Thyroxine to 3, 3',5'-triiodothyronine (T3) and 3,3',5-triiodothyronine (Reverse T3).  J Clin Endocrinol Metab 44:85-90, 1977.

17.   Burman KD, Dimond RC, Wright FD, Earll JM, Bruton J, Wartofsky L.  A Radioimmunoassay for Reverse T3: Assessment of Thyroid Gland Content and Serum Measurement in Conditions Normal and Altered Thyroidal Economy and Following Administration of TRH and TSH.  J Clin Endocrinol Metab 44:660-672, 1977.

18.   Burman KD, Strum D, Dimond RC, Djuh YY, Wright FD, Earll JM, Wartofsky L.  A Radioimmunoassay for 3,3'-L-Diiodothyronine (3,3'T2).  J Clin Endocrinol Metab 45:339-352, 1977.

19.   Burman KD, Vigersky RA, Loriaux DL, Strum D Djuh YY, Wright FD, Wartofsky L.  Investigation Concerning Thyroxine Deiodinative Pathways in Patients with Anorexia Nervosa.  Aven Press, Anorexia Nervosa, ed.  Vigersky, RA, 255-261, 1977.

20.   Thrall JH, Burman KD, Gillin MT, Corcoran RJ, Johnson MC, Wartofsky L.  Solitary Tutonomous Thyroid Nodules: comparison of Fluorescent and Pertechnetate Imaging.  J Nucl Med 18:1064-1068, 1977.

21.   Burman KD, Lukes Y, Wright FD, Wartofsky L.  Reduction in Hepatic T3 Binding Capacity Induced by Fasting.  Endocrinology 101:1331-1334, 1977.

22.   Thrall JH, Burman KD, Wartofsky L, Corcoran RJ, Johnson MC, Gillin MT.  Dicordant Imaging of a Thyroid Nodule with 130I and Flourescent Scans, Radiology 128:705-706, 1978.

23.   Smallridge RC, Wartofsky L, Desjardins RE, Burman KD.  Reverse Production Rates in Thyrotoxic, Euthyroid, and Hypothyroid Subjects.  J Clin Endocrinol Metab 47:345-349, 1978.

24.   Smallridge RC, Wartofsky L, Chopra IJ, Solomon DIH, Dimond RC, Marinelli PV, Broughton RE, Earll JM, Burman KD.  Neonatal Thyrotoxicosis: Relationship LATS-Protector to Alteration in Serum T4, T3, Reverse T3, and 3, 3'T2 Concentrations.  J Pediatrics 93:118-120, 1978.

25.   Burman KD, Djuh YY, Dimond RC, Wartofsky L.  Failure of 3, 3'T2 Administration to Alter TSH and Prolactin Responses to TRH Stimulation.  Metabolism 27:677-683, 1978.

26.   Smallridge RC, Wartofsky L, Desjardins RE, Burman KD.  Metabolic Clearance and Production Rates of 3, 3'5-Triiodothyronine in Hyperthyroid, Euthyroid, and Hypothyroid Subjects.  J Clin Endocrinol Metab 47:345-349, 1978

27.   Corrigan DF, Wartofsky L, Dimond RC, Schaaf M, Rogers JC, Wright FD, Burman KD.  Parameters of Thyroid Function in Patient With Active Acromegaly.  Metabolism 27:209-216, 1978.

28.   Burman KD, Wright FD, Smallridge RC, Green BJ, Georges LP, Wartofsky L.  A Radioimmunoassay for 3',5'-diiodothyronine.  J Clin Endocrinol Metab 47:1059-1064, 1978.

29.   Glass AR, Mellitt R, Burman KD, Wartofsky L, Swerdloff RS.  Serum T3 in Undernourished Rats: Dependence on Dietary Composition Rather than Total Calorie or Protein Intake.  Endocrinology 102:1925-1928, 1978.

30.   Burman KD, Harvey GS, O’Brian JT, Georges LP, Bruton J, Wright FD, Dimond RC, Wartofsky L.  Glucose Modulation of Peripheral Thyroid Hormone Metabolism.  Metabolism 28:291-299, 1979.

31.   Smallridge RC, Wartofsky L, Green BJ, Miller FC, Burman KD.  3'L-monoiodothyronine (3'T1): Development of a Radioimmunoassay and Demonstration of In Vivo Conversion From 3',5'-diiodothyronine.  J Clin Endocrinol Metab 48:32-36, 1979.

32.   Burman KD, Dinterman R, Wartofsky L, Kesler P, Wannemacher RW.  The Effect of T3 and Reverse T3 Administration on Muscle Protein Catabolism during Fasting as Measured by 3 Methylhistidine Excretion.  Metabolism 28:805-813, 1979.

33.   Burman KD, Smallridge RC, Osburne R, Dimond RC, Whorton NE, Kesler P, Wartofsky L.  Nature of Suppressed TSH Secretion during Undernutrition: Effect of Fasting and Refeeding on TSH Responses to Prolonged TRH Infusions.  Metabolism 29:46-52, 1980.

34.   Burman KD, Smallridge RC, Jones L, Ramos EA, O’Brian JT, Wright FD, Wartofsky L.  Glucagon Kinetics in Fasting: A Metabolic Event Associated with Physiologic Alterations in Serum T3.  J Clin Endocrinol Metab 51:1158-1165, 1980.

35.   Becker RA, Wilmore DW, Godwin CW, Zitzka CA, Wartofsky L, Burman KD, Mason AD, Pruitt BA.  Free T4, Free T3 and Reverse T3 in Critically Ill, Thermally Injured Patients.  J of Trauma 20:713-721, 1980.

36.   Burman KD, Latham KR, Djuh YY, Smallridge RC, Tseng YL, Lukes YG, Maunder R, Wartofsky L.  Solubilized Nuclear Thyroid Hormone Receptors in Circulating Human Mononuclear Cells: Evidence for Increased Maximum Binding Capacities in Fasted Obese Subjects.  J Clin Endocrinol Metab 51:106, 1980.

37.   O’Brian JT, Bybee DE, Burman KD, Osburne RC, Ksiazek MR, Wartofsky L, Georges LP.  Thyroid Hormone Homeostasis in States of Relative Calorie Deprivation.  Metabolism 29:721, 1980.

38.   Pangaro L, Burman KD, Wartofsky L, Cahnmann HJ, Smallridge RC, O’Brian JT, Wright FD, Latham KR.  Radioimmunoassay for 3, 5-diiodothyronine (3,5T2) and Evidence for Dependence on Conversion From T3.  J Clin Endocrinol Metab 6:1075-1081,1980.

39.   Boehm TM, Burman KD, Barnes S, Wartofsky L.  Lithium and Iodide Combination Treatment for Thyrotoxicosis.  Acta Endocrinologica 94:174-183, 1980.

40.   Wray HL, Burman KD, Smallridge RC, Alford JP, Butler VM, Wright FD, Wartofsky L.   Effect of T3 and Reverse T3 Administration on Serum Tri-Di-and Monoiodothyronines and Plasma Cyclic Nucleotide in Sheep.  Endocrinology 107:1081, 1980.

41.   Thompson P, Burman KD, Lukes YG, McNeil JS, Jackson BD, Latham KR, Wartofsky L.  Uremia Decreases Nuclear T3 Receptors in Rats.  Endocrinology 107:1081, 1980.

42.   Boehm TM, McLain J, Burman KD, deShazo R, Wartofsky L.  Iodine Treatment of Iodine-induced Thyrotoxicosis.  J Endocrinol Invest 3: 419-424, 1980.

43.   Burman KD, Lukes YG, Latham KR, Wartofsky L.  Ipodate and 8-anilino-1-naphthalene Sulfonic Acid Block Receptor Binding of T3 in Rat Liver.  Hormone and Metabolic Research 12:685-687, 1980.

44.   Maxon HR, Burman KD, Premachandra BN.  Euthyroid Familial Hyperthyroxinemia [Letter].  N Eng J Med 302:1263, 1980.

45.   Wartofsky L, Latham KR, Djuh YY, Burman KD.  Alterations in T3 and T4 Receptor Binding in Fasting and Diabetes Mellitus.  Life Sci 28:1683-1691, 1981.

46.   Burman KD, Bongiovanni R, Garis RK, Wartofsky L, Boehm T.  Measurement of Serum T4 Levels by High Performance Liquid Chromatography.  J Clin Endocrinol Metab 53:909, 1981.

47.   Biogiovanni R, Burman KD, Garis RK, Boehm T.  HPLC Measurement of Dansyl-thyroxine in Femtomole Range.  J Liquid Chromatography 4(5):813-24, 1981.

48.   DeRuter H, Burman KD, Wartofsky L, Taylor S.  Effects of Thyroid Hormone on the Insulin Receptor in Rat Liver Membranes.  Endocrinology 110, 1981.

49.   Maxon HR, Burman KD, Premachandra BN, Chen IW, Burger A, Levy P, Georges LP.  Familial Elevations of Total and Free Thyroxine in Healthy, Euthyroid Subjects Without Detectable Binding Protein Abnormalities.  Acta Endocrinol 100:224

50.   Smallridge RC, Wartofsky L, Burman KD.  Thyroid Carcinoma and Hodgkin’s Disease.  Annals Int Med 94:412-413, 1981.

51.   Burman KD, Lukes YG, Latham KR, Smallridge RC, Wartofsky L.  The Effect of Dexamethasone, Diet Control and Hyperglycemia on Murine Hepatic T3 Receptors.  Life Sciences 28:1701-1712, 1981.

52.   Wartofsky L, Latham KR, Djuh YY, Burman KD.  Human T3 Receptors in Fasting and Diabetes Mellitus.  Life Sciences 28:1683-1691, 1981.

53.   Smallridge RC, Smith CE, Wright FD, Wartofsky L, Burman KD.  Metabolic Clearance Rate and Production Rate of 3'5'T2 in Hyper- and Hypothyroidism.  J Clin Endocrinol Metab 52:722-730, 1981.

54.   Smallridge RC, Burman KD, Ward KE, Dimond RC, Wright KR, Wartofsky L.  3',5'-diiodothyronine to 3'-monoiodothyronine Conversion in the Rat: Enzyme Characteristics and Evidence for Two Distinct 5'-Deiodinases.  Endocrinology 108:2336, 1981.

55.   Glass AR, Burman KD, Dahms WT, Boehm TM.   Endocrine Function in Human Obesity.  Metabolism 30:89-104, 1981.

56.   Zwillich C, Martin B, Rose E, Charles A, Hofeldt F, Burman KD.  Lack of Effects of Dense Beta Sympathetic Blockade on Metabolic Rate and Respiratory Resource to Carbohydrate Feeding.  Metabolism 30:451, 1981.

57.   Wartofsky L and Burman KD.  Alterations in Thyroid Function in Patients with Systemic Illness: The “Euthyroid Sick Syndrome.”  Endocrin Rev 3:164-217, 1982. 

58.   Swartz M, Burman KD, Salen G.  Cerebrotedinous Xanthomatsis: A Potentially Treatable Lethal Disease Presenting With Cataracts.  Amer J Medical Sciences 283(3):147-152, 1982.

59.   Smallridge RC, Wartofsky L, Burman KD.  The Effect of Experimental Hyper-and Hypothyroidism on 5'-monodeiodination of Reverse T3 and 3',5'-diiodothyronine by Rat Liver and Kidney.  Endocrinology 11:2066-2069, 1982.

60.   Thompson PT, Burman KD, Wartofsky.  Iodothyronines Levels in Human Cerebrospinal Fluid.  J Clin Endocrinol Metab 54(3):653-655, 1982.

61.   Burman KD, Boehm T, Bongiovanni R.  Compendium of the Joint FDA/USP Workshop on Drug and Reference Standards, for Insulins, Somatropins, and Thyroid Axis Drugs.  NIH publications, 1982.

62.   Borst GC, Premachandra BN, Burman KD, Osburne RC.  Euthyroid Familial Hyperthyroxenemia Due to an Abnormal Thyroid Hormone Binding Protein.  Amer J Med 73:293-289, 1982.

63.   Burman KD.  “Hanging From the Masthead”: Reflection on Authorship.  Ann Int Med 97:602-605, 1982.

64.   Smallridge RC, Glass AR, Wartofsky L, Ward KE, Latham KR, Burman KD.  Investigations into the Etiology of Elevated Serum T3 Levels in Protein Malnourished Rats.  Metabolism 31:538, 1982.

65.   Borst GC, Eil C, Burman KD.  Euthyroid Hyperthyroxinemia.  Ann Intern Med 98366-78.

66.   Borst GC, Osburne RC, O’Brian JT, Georges LP, Burman KD.  Fasting Decreases TSH Responsiveness: A Potential Cause of Misinterpretation of Thyroid Function Tests in the Critically Ill.  J Clin Endocrinol Metab 57:380-383, 1983.

67.   Baker Jr JR., Lukes YG, Smallridge RC, Berger M, Burman KD.  Partial Characterization and Clinical Correlation of TSH Displaceable Guinea Pig Membrane Binding Human Immunoglobulins as Evaluated by Direct Enzyme Immunoassay. J Clinical Investigation 72:1487-1497, 1983.

68.   Chernow B, Burman KD, Johnson DL, McGuire RA, O'Brian JT, Wartofsky L, Georges LP.  T3 May Be A Better Agent Than T4 in the Critically Ill              Hypothyroid Patient: Evaluation of Transport Across the Blood‑Brain Barrier in a Primate Model.  Crit Care Med 11:99‑104, 1983.

69.   Osburne RC, Myers EA, Rodbard D, Burman KD, Georges LP, O'Brian JT. Adaptation to Hypocaloric Feeding: Physiologic Significance of the Fall in Serum T3 as Measured by the Pulse Wave Arrival Time (Qkd). Metabolism 32:9‑13, 1983.

70.   Wortsman J, Premachandra BN, Williams K, Burman KD, Hay ID, Davis PJ. Familial Resistance to Thyroid Hormone Associated with Decreased Transport across the Plasma Membrane.  Ann Int Med 98:904‑909, 1983.

71.   Burman KD, Smallridge RC, Burge JR, Carlson D, Wartofsky L.  Ipodate Restores the Fasting Induced Decrement in TSH Secretion.  J Clin  Endocrinol Metab 57:597‑602, 1983.

72.   DeRuyter H, Burman KD, Wartofsky L, Smallridge RC.  Thyrotropin Secretion in Starved Rats is Enhanced by Somatostatin Antiserum.  Hormone and Metabolic Research 16:92‑96, 1984.

73.   Wartofsky L and Burman KD.  Effects of Drugs on Peripheral Thyroxine Metabolism.  Horm Metab Res Suppl 1984;14:105-108, 1984.

74.   Glass AR, Vigersky RA, Rajatanavin R, Smallridge RC, Wartofsky L, Burman KD.  Low Serum Thyroxine and High Serum Triiodothyronine in Nephrotic Rats:  Etiology and Implications for Bioavailability of Protein-Bound Hormone.  Endocrinology 114:1745‑1753, 1984.

75.   Margolick JB, Hsu S‑M, Volkman DJ, Burman KD, Fauci AS. Immunohistochemical Characterization of Intrathyroid Lymphocytes in Graves' Disease: Interstitial and Intraepithelial Populations.  Amer J Med 76:815‑821, 1984.

76.   Baker Jr JR, Lukes YG, Burman KD.  Production, Isolation and Characterization of Rabbit Anti‑idiotypic Antibodies Directed against Human Antithyrotrophin Receptor Antibodies.  J of Clin Invest 74:488‑495, 1984.

77.   Carlson DE and Burman KD.  The Effectiveness of Carefully Monitored Modified Fast as Adjuvant Therapy for Exogenous Obesity in Active Duty Personnel.  Military Medicine 149:669‑671, 1984.

78.   McDermott MT, Burman KD, Hofeldt FD, Kidd GS.  Lithium Associated Thyrotoxicosis.  Amer J Med 80:1245-1248, 1984.             

79.   Clark IJ, Wright PJ, Chamley WA, Burman KD.  Differences in the Reproductive Endocrine Status of Ewes in the Early Post-Partum Period and during Seasonal Anoestrus.  J Reprod Fertil 70:591-597, 1984.

80.   Smallridge RC, Whorton NE, Burman KD, Ferguson EW.  Effects of                 Exercise and Physical Fitness on the Pituitary‑Thyroid Axis and on Prolactin Secretion in Male Runners.  Metabolism 34:949, 1985.

81.   Burman KD, Lukes YG, Wartofsky L, Djuh Y‑Y, Baker Jr JR.  Preparation of Biotinylated Receptor Purified Graves' IgG: A Simple Technique Allowing Direct Functional Assessment of TSH Receptor Antibody Binding to Membranes. In Autoimmunity and the Thyroid, ed. Walfish PG, Wall JR, Volpe R.  Academic Press, Montreal, 1985.

82.   Zaloga GP, Chernow B, Smallridge RC, Zajtchuk R, Hall‑Boyer K, Hargraves R, Lake CR, Burman KD.  A Longitudinal Evaluation of Thyroid Function in Critically Ill Surgical Patients.  Ann Surg 201:456‑464, 1985.

83.   Smallridge RC, Chernow B, Snyder R, Zaloga GP, Burman KD. ngiotensin-Converting Enzyme: A Potential Marker of Tissue Hypothyroidism in Critical Illness.  Arch Intern Med 145(10):1829-32, 1985.

84.   Raines KB, Baker Jr JR., Lukes YG, Burman KD.  Anti‑Thyrotropin Antibodies in the Sera of Graves' Disease.  J of Clin Endocrinol Metab 61:217‑222, 1985.

85.   Zucker A, Chernow B, Fields AI, Hung W, Burman KD.  Evaluation of Thyroid Function in Critically Ill Children.  J Pediatr 107:552-554, 1985.

86.   Tseng Y‑C, Burman KD, Baker JR, Wartofsky L.  A Rapid and Sensitive Enzyme ‑ Linked Immunoassay (EIA) for Human Thyrotropin (TSH).  Clin Chem 31:1131, 1985.

87.   Hennessey JV, Burman KD, Wartofsky L.  The Equivalency of Two L‑Thyroxine Preparations.  Annals Int Medicine 6:770‑773, 1985.

88.   Hay ID, Gorman CA, Burman KD, Jian N‑S.  Stereospecific Determination and In Vivo Monodeiodination of Thyroxine Enantiomers in Euthyroid Man.  Metabolism 34:266‑271, 1985.

89.   Weetman AP, Volkman DJ, Burman KD, Gerrard TL, Fauci AS.  The In Vitro Regulation of Human Thyrocyte HLA‑DR Antigen Expression.  J Clin Endocrinol Metab 61:817-24, 1985.

90.   Weetman AP, Volkman DJ, Burman KD, Fauci AS.  Activation, Proliferation and Differentiation of Circulating B Cells in Autoimmune Thyroid Disease.  J Immunology 135:3138‑3143, 1985.

91.   Raines KB, Baker Jr JR., Lukes YG, Wartofsky L, Burman KD.  Antithyrotropin Antibodies in the Sera of Graves' Disease Patients. Clin Endocrinol Metab 61:217, 1985.

92.   Hennessey JV, Burman KD, Wartofsky L.  Thyroxine Bioequivalency.  Ann Intern Med 103:647, 1985 (Letter).

93.   Burman KD, Ferguson EW, Djuh YY, Wartofsky L, Latham K.  Beta Receptors in Peripheral Mononuclear Cells Increase Acutely during Exercise.  Acta Endocrinol 109:563-568, 1985.

94.   Burman KD and Baker Jr JR.  Immune Mechanisms in Graves' Disease.  Endocrine Rev 6:183-232, 1985.

95.   Graham GD and Burman KD.  Radioiodine Treatment of Graves' Disease: An Assessment of its Potential Risks.  Ann Intern Med 105:901‑905, 1986.

96.   Burman KD.  Graves' Disease: Studies Concerning TSH‑receptor Antibody Formation and Action.  Clinical Research 34:432‑437, 1986.

97.   Hennessey JV, Evaul JE, Tseng YC, Burman KD, Wartofsky L.  L‑thyroxine Dosage: A Re‑evaluation of Therapy with Contemporary Preparations.  Ann Int Med 105:11‑15, 1986.

98.   Reed HL, Burman KD, Shakir KM, O'Brian JT.  Alterations in the Hypothalamic‑Pituitary‑Thyroid Axis after Prolonged Residence in Antarctica.  Clinical Endocrinol 25:55‑65, 1986.

99.   Sack J, Baker JR Jr., Weetman AP, Wartofsky L, Burman KD.  The Role of Antibody‑Dependent Cytotoxicity and Natural Killer Cells in Hashimoto's Disease.  In Frontiers in Thyroidology, vol. 2.  G. Medeiros‑Neto and E. Gaitan, eds.  Plenum Publishing Co, 1986.

100.           Weetman AP, Volkman DJ, Burman KD, Margolick JB, Petrick P, Weintraub BD, Fauci AS.  The Production and Characterization of Thyroid‑Derived T-Cell Lines in Graves' Disease and Hashimoto's Thyroiditis.  Clin Immunology Immunopathol 39:139-50, 1986.

101.           Hennessey JV, Evaul JE, Tseng YC, Burman KD, Wartofsky L.  Re‑evaluation of L‑thyroxine Dose.  Ann Intern Med 105:797‑798, 1986 (Letter).

102.           Weetman AP, Smallridge R, Hayslip C, Burman KD.  Multiple Autoantigenic Determinants in Thyroid Autoimmunity.  In "Thyroid Autoimmunity: Memories and Perspectives."  Plenum Publishing Corp, 1986.

103.           Burman KD and Baker Jr JR.  Autoimmune Graves' Disease.  The Bridge Newsletter, 1986.

104.           Weetman AP, Nutman TB, Burman KD, Baker JR, Fauci AS Volkman DJ. Heterogeneity of Thyroid Autoantigens Identified by Immunoblotting. Clin Immunol and Immunopathology 43:333‑342, 1987.

105.           Weetman AP, Smallridge RC, Nutman TB, Burman KD.  Persistent Thyroid Autoimmunity after Subacute Thyroiditis.  J Clin and Lab Immuno 23:1‑6, 1987.

106.           Butkus NE, Burman KD, Smallridge RC.  Angiotensin‑Converting Enzyme Activity Decreases During Fasting.  Horm Metab Res 19:76-7, 1987.

107.           Solomon BL, Evaul JE, Burman KD, Wartofsky L.  Remission Rates with Antithyroid Drug Therapy: Continuing Influence of Iodine Therapy.  Ann Intern Med 107:510‑512, 1987.

108.           Ahmann A, Baker JR, Jr., Weetman AP, Wartofsky L, Nutman TB, Burman KD. Antibodies to Porcine Eye Muscle in Patients with Graves' Ophthalmopathy: Identification of Serum Immunoglobulins Directed against Unique Determinants by Immunoblotting and Enzyme‑linked Immunosorbent Assay.  J Clin Endocrinol Metab 64: 454‑460, 1987.

109.           Weetman AP, Nutman TB, Baker JR, Jr., Burman KD.  Demonstration by Immunoblotting of Heterogeneity in the Autoantibody Response Directed against Fat Cells in Graves' Disease.  FEBS Letters 211:69‑72, 1987.

110.           Burman KD.  "Hypothyroidism," Conn's Current Theory, ed. Rakel R, W.B. Saunders, Co., p. 521, 1987.

111.           Tseng YC, Burman KD, Baker Jr JR., D'Avis J, Wartofsky L.  Intrinsic Abnormality of Thyroid Cells from a Patient with a Brobdingnagian Goiter. J Endocrinological Invest 10:517-522, 1987.

112.           Ahmann AJ and Burman KD.  The Role of T Lymphocytes in Autoimmune Thyroid Disease.  Endocrinology and Metabolism Clinics of North America, 16:287‑327, 1987.

113.           Burman KD, Djuh YY, LaRocca RV, Nunes ME, D'Avis JC, Nicholson DE, Wartofsky L.  C‑myc Expression in the Thyroid I: Normal, Adenomatous, and Cancerous Thyroid Tissue.  Horm Metab Res (Suppl) 17:63‑65, 1987.

114.           Nunes ME, Djuh YY, LaRocca RV, Nicholson DE, Baker JR Jr., Wartofsky L. D'Avis JC, Burman KD.  C‑myc Expression in the Thyroid II: Thyrocytes and Peripheral and Intrathyroidal Lymphocytes from Patients with Autoimmune Thyroid Disease.  Horm Metab Res (Suppl) 17:66‑69, 1987.

115.           Sack J, Baker JR Jr., Weetman AP, Wartofsky L, Burman KD.  Thyrocyte Specific Killer Cell Activity is Decreased in Patients with Thyroid Carcinoma.  Cancer 59:1914‑1917, 1987.

116.           Burman KD, Smallridge RC, Burge JR, O'Brian JT, Wartofsky L.  Iodide              Administration Enhances Thyrotropin Responsiveness to Thyrotropin-Releasing Hormone during Fasting: Evidence for Normal Pituitary Feedback Regulation.  Clin Endocrinol 26:9-15, 1987.

117.           Dolev E, Deuster PA, Solomon B, Trostmann V, Burman KD.  Alterations in Magnesium and Zinc Metabolism in Thyroid Disease.  Metabolism 37:61‑67, 1988.

118.           Baker JR Jr., Saunders NB, Kaufersch W, Burman KD.  The Development of Human Monoclonal Antibodies from Graves' Disease Patients which Demonstrate the Ability to Inhibit TSH‑mediated Production of Cyclic‑Adenosine Monophosphate in Thytocytes. J Immunology 140:2593‑2599, 1988.

119.           Nuovo JA, Baker JR Jr., Wartofsky L, Lukes YG, Burman KD.  Autoantibodies to Insulin are Present in the Sera of Patients with Autoimmune Thyroid Disease.  Diabetes 37:317‑320, 1988.

120.           Wortsman J, McConnachie P, Baker JR Jr., Burman KD.  Immunoglobulins that Cause Thyrocyte Proliferation from a Patient with Graves' Disease and an Enlarged Thymus.  Am J Med 85:117‑21, 1988.

121.           Margolick JB, Weetman AP, Burman KD.  Immunohistochemical Analysis of Intrathyroid Lymphocytes in Graves' Disease: Evidence of Activated T Cells and Interferon‑Gamma.  Clin Immunol and Immunopathology 47:208‑218, 1988.

122.           Kaulfersch W, Baker JR Jr., Burman KD, Ahmann AJ, D'Avis JC, Waldmann TA.  Immunoglobulin and T Cell Gene Rearrangements Indicate that the Immune Response in Autoimmune Thyroid Disease (AITD) is Polyclonal.  J Clin Endocrinol Metab 66:958‑963, 1988.

123.           Baker JR, Saunders NA, Tseng YC, Wartofsky L, Burman KD.  Seronegative Hashimoto’s Thyroiditis with Thyroid Autoantibody Production Localized to the Thyroid.  Ann Intern Med 108:26‑30, 1988.

124.           Reed HL, Ferreiro JA, Shakir KMM, Burman KD, O'Brian JT.  Pituitary and Peripheral Hormone Responses to T3 Administration during Antarctic Residence. Amer J Physiology 254:E733‑739, 1988.

125.           Burman KD.  "Hypothyroidism," in Current Therapy in Allergy, Immunology, and Rheumatology, eds. Fauci AC, Lichtenstein LM, B.C. Decker, Inc., 1988.

126.           Hayslip CC, Baker JR Jr., Wartofsky L, Klein TA, Opsahl MS, Burman KD.  Natural Killer Cell Activity and Serum Autoantibodies in Women with Postpartum Thyroiditis.  J Clin Endocrinol Metab 66:1089‑93, 1988.

127.           Burman KD, Baker JR, Tseng YC, Saunders N, Solomon B, Wartofsky L.  Eponyms (Letter).  Ann Intern Med 108:635, 1988.

128.           Premachandra BN, Burns TW, Bregant R, Williams IK, Burman KD.  Persistence of Low Serum Thyroid Hormone Levels in a Graves' Disease Patient Receiving              

129.           Tseng YC, Burman KD, Schaudies RP, Ahmann A, D'Avis J, Geelhoed GW, Wartofsky L.  Effects of Epidermal Growth Factor on Thyroglobulin and Adenosine 3,5'‑Monophosphate Production by Cultured Human Thyrocytes.              J Clin Endocrinol Metab 69:771‑775, 1989.

130.           Tseng YC, Sellitti DF, Ahmann AJ, Burman KD, D'Avis JC, Wartofsky L. Thyrotropin Modulates Receptors for Atrial Natriuretic Factor on Intact Human Thyroid Cells.  Amer J Med Sci 298:15‑19, 1989.

131.           Kaulfersch W, Baker JR Jr., Burman KD, Fiocchi C, Ahmann AJ, D'Avis JC, Waldmann TA.  Molecular Genetic Detection of Polyclonal Immune Response in Autoimmune Thyroiditis and Inflammatory Bowel Diseases. Monatsschr Kinderheilkd 137:610‑615, 1989.

132.           Sack, J, Zilberstein D, Barile MF, Wartofsky L, Lukes YG, Baker JR Jr, Burman KD.  Binding of Thyrotropin to Selected Mycoplasma Species: Detection of Serum antibodies against a Specific Mycoplasma Membrane Antigen in Patients with Auto‑immune Thyroid Disease.  J Endocrinol Invest 12:77‑86, 1989.

133.           Burman KD, Anderson JH, Wartofsky L, Mong DP, Jelinek JJ.  Management of Patients with Thyroid Carcinoma: Application of Thallium-201 Scintigraphy and Magnetic Resonance Imaging.  J Nucl Med 31: 1958-64,1990.

134.           Reed HL, Brice D, Shakir KM, Burman KD, D'Alesandro M, O'Brian JT.  Decreased Free Fraction of Thyroid Hormones after Prolonged Antarctic Residence.  J Appl Physiol 69:1467-72, 1990.

135.           Tseng YCL, Lahiri S, Sellitti DF, Burman KD, D'Avis JC, Wartofsky L. Characterization by Affinity Cross‑linking of a Receptor for Atrial Natriuretic Peptide in Cultured Human Thyroid Cells Associated with Reductions in Both Adenosine 3'5'‑monophosphate Production and Thyroglobulin Secretion.  J Clin Endocrinol Metab 70:528‑533, 1990.

136.           Troumbley PF, Burman KD, Rinke WJ, Lenz ER.  A Comparison of the Health Risk, Health Status, Self‑Motivation, Psychological Symptomatic Distress, and Physical Fitness of Overweight and Normal Weight Soldiers.  Military Med 155:424‑429, 1990.

137.           Norby EH, Neutze J, Van Nostrand D, Burman KD, Warren RW.  Nasal Radioiodine Activity: A Prospective Study of Frequency, Intensity and Pattern.  J Nucl Med 31:52‑54, 1990.

138.           Burman KD.  "Hashimoto's Thyroiditis" in Current Therapy in Internal Medicine, ed. Jerome Kassirei, 1990.

139.           Reed HL, Silverman ED, Shakir KMM, Dons R, Burman KD, O'Brian JT.  Changes in Serum Triiodothyronine Kinetics after Prolonged Antarctic Residence: The Polar T3 Syndrome.  J Clin Endocrinol Metab 70:965-974, 1990.

140.           Reed HL, Brice D, Shakir KMM, Burman KD, D'Alesandro MM, O'Brian JT.  Decreased Free Fraction of Thyroid Hormones after Prolonged Antarctic Residence. J Appl Physiology 69:1467‑1472, 1990.

141.           Burman KD.  Is Long‑term Thyroxine Therapy Safe? (Editorial) Arch Intern Med, 150:2010‑2013, 1990.

142.           Smallridge RC, Burman KD, Wartofsky L.  Malabsorption of Thyroxine, Calcium, and Vitamin D in a Thyroparathyroidectomized Woman: Efficacy of Therapy with Medium Chain Triglyceride Oil.  Military Med 155:156‑158, 1990.

143.           Burman KD.  "Thyrotoxicosis," in Principles and Practices of Endocrinology and Metabolism, ch. 34, pp. 331-347.  K. Becker, ed. J.B. Lippincott, 1990.

144.           Burman KD, Anderson JH, Wartofsky L, Mong DP, Jelinek JJ.  Management of Patients with Thyroid Carcinoma: Application of Thallium‑201 Scintigraphy and Magnetic Resonance Imaging.  J Nucl Med 31:1958‑1964, 1990.

145.           Tseng YC, Burman KD, Lahiri S, D'Avis JC, Abdelrahim M, Wartofsky L. Thyrotropin Modulates Receptor‑mediated Processing of the Atrial Natriuretic Peptide Receptor Complex in Cultured Thyroid Cells.  J Clin Endocrinol Metab 72:669‑674, 1991.

146.           Burman KD.  "Immunoassays, Nonradionucleotide" in Encyclopedia of Human Biology, pub. Harcourt, Brace, and Jovanovich, and Academic Press, ed. Renate Dulbecco, 4:351-56, 1991.

147.           Baker JR, Miller FW, Steinberg AD, Burman KD.  Thyroid Stimulating and Thyrotropin Binding Inhibitory Immunoglobulin Activity in Patients with Systemic Lupus Erythematosus having Thyroid Function Abnormalities.  Thyroid 1:229‑234, 1991.

148.           Fein HG, Burman KD, Djuh YY, Usala SJ, Bale AE, Weintraub BD, Smallridge RC.  Tight Linkage of the Human c‑Erb A Beta Gene with the Syndrome of Generalized Hormone Resistance is Present in Multiple Kindreds. J Endocrinol Invest              14:219‑223, 1991.

149.           Francis T, Burch HB, Cai WY, Lukes Y, Peele M, Carr FE, Wartofsky L, Nicholson D, Burman KD.  Lymphocytes Express Thyrotropin Receptor Specific Messenger RNA as Detected by the PCR Techniques.  Thyroid 1:223-228, 1991.

150.           Burch HB, Nagy EV, Lukes YG, Cai WY, Wartofsky L, Burman KD.  Nucleotide and Amino Acid Homology between the Human Thyrotropin Receptor and the HIV-1 Nef Protein: Identification and Functional Analysis.  Biochem &  Biophys Res Communications 181:498-505, 1991.

151.           Burman KD.  Treatment of Autoimmune Ophthalmopathy.  The Endocrinologist 1:102‑110, 1991.

152.           Humphrey M, Mosca J, Baker JR Jr, Drabick JJ, Carr FE, Burke DS, Wartofsky L, Djuh YY, Burman KD.  Absence of Retroviral Sequences in Graves' Disease.  Lancet 337:17-8, 1991.

153.           Humphrey ML and Burman KD.  Retrosternal and Intrathoracic Goiter.  The Endocrinologist. 2:195-201, 1992.

154.           Cai WY, Lukes YG, Burch HB, Djuh YY, Carr FE, Wartofsky L, Rhooms P, D'Avis JC, Baker JR Jr., Burman KD.  Analysis of Human TSH Receptor Gene and RNA Transcripts in Patients with Thyroid Disorders.  Autoimmunity 13:43-50, 1992.

155.           Haibach H, Burns TW, Carlson HE, Burman KD, Deftos LJ.  Multiple Hamartoma Syndrome (MHS, Cowden's Disease) Associated with Renal Cell Carcinoma and Primary Neuroendocrine Carcinoma of the Skin (Merkel Cell Carcinoma).  Am  J Clin Pathol 97:705-12, 1992

156.           Burman KD, Djuh Y-Y, Nicholson D, Rhooms P, Wartofsky L, Fein HG, Usala SJ, Hao E-H, Bradley WEC, Berard J, Smallridge RC.  Generalized Thyroid Hormone Resistance: Identification of an Arginine to Cystine Mutation in Codon 315 of the C-erb A Beta Thyroid Hormone Receptor.  J Endocrinol Invest 15:573-79, 1992.

157.           Burman KD, Kaplan KA.  Autoimmune Ophthalmopathy: Present Concepts Regarding Diagnosis, Analysis and Treatment.  Guthrie Medical J 61:5-14, 1992.

158.           Jackson S, Tseng Y-C, Lahiri S, Burman KD, Wartofsky L.  Receptors for Endothelin in Cultured Human Thyroid Cells and Inhibition by Endothelin of Thyroglobulin Secretion. J Clin Endocrinol 75:388-92, 1992.

159.           Nagy EV, Burch HB, Mahoney K, Lukes YG, Morris JC III, Burman KD.  Graves' IgG Recognizes Linear Epitopes in the Human Thyrotropin Receptor.  Biochem & Biophys    Res Comm 188:28-33, 1992.

160.           Tseng Y-C, Burman KD, Lahiri S, D'Avis J, Wartofsky L.  Thyrotropin Modulation of Epidermal Growth Factor (EGF) Binding to Receptors on Cultured Thyroid Cells.   Thyroid 2:181-187, 1992.

161.           Nagy E, Burman KD.  Enzyme-linked Immunosorbent Assays (ELISA).  In press, Handbook of Hormonal Assay Techniques, Academic Press, Inc.

162.           Burch HB, Nagy EV, Kain KC, Lanar DE, Carr FE, Wartofsky L, Burman KD. Expression Polymerase Chain Reaction for the In Vitro Synthesis and Epitope Mapping of Autoantigen: Application to the Human Thyrotropin Receptor.  J Immunol Methods 158:123-30, 1993.

163.           Solomon BL, Wartofsky L, Burman KD.  Adjunctive Cholestyramine Therapy for Thyrotoxicosis.  Clinical Endocrinology 38:39-43, 1993.

164.           Tseng Y-C, Lahiri S, Jackson S, Burman KD, Wartofsky L.  Endothelin Binding to Receptors by Human Thyroid Follicular Cells: Effects of Transforming Growth Factor-ß and Thyrotropin.  J Clin Endocrinol Metab 76:156-61, 1993.

165.           Solomon BL, Burman KD.  The Prevalence of Fractures in Postmenopausal Women with Thyroid Disease.  Thyroid 3:17-23, 1993.

166.           Burch HB, Cranston TJ, Anderson JH, Burman KD.  Combined Free Thyroxine and   Sensitive TSH Testing in a Large Clinical Practice: Comparison with Conventional Thyroid Function Testing.  Submitted for publication, 1993.

167.           Burman KD, "Thyroid Hormones," ch. 34, pp. 671-691, in The Pharmacologic Approach to the Critically Ill Patient, 2nd edition.  Chernow B, Williams and Wilkins (eds.), 1988.  Third edition in press, 1993.

168.           Mengistu M, Lukes YG, Nagy EV, Burch HB, Carr FE, Lahiri S, Burman KD.  TSH Receptor Gene Expression in Retroocular Fibroblasts.  Submitted for publication, 1993.

169.           Peele ME, Carr FE, Baker JR Jr, Wartofsky L, Burman KD.  TSH Beta Subunit Gene Expression in Human Lymphocytes. Amer J Med Sci 305:1-7, 1993.

170.           Burch HB, Nagy E, Kain K, Lanar D, Carr FE, Wartofsky L, Burman KD.  Expression PCR for the In Vitro Synthesis of Autoantigen: Application to the Human Thyrotropin Receptor.  J Immunol Methods 158:123-30, 1993.

171.           Nagy E, Burch HB, Lukes YG, Kosugi S, Kohn LD, Burman KD.  Immunogenicity of a Unique Region of the Human Thyrotropin Receptor.  Journal of Endocrinological Investigation 16:485-93, 1993.

172.           Burch HB, Nagy EV, Kain KC, Lanar DE, Carr FE, Wartofsky L, Burman KD. Expression Polymerase Chain Reaction for the In Vitro Synthesis and Epitope Mapping of Autoantigen: Application to the Human Thyrotropin Receptor.  J Immunol Methods 158:123-30, 1993.

173.           Nagy EV, Burch HB, Burman KD.  Unidirectional Shift of the Dominant T Cell               Epitope in the Human Thyrotropin Receptor in Graves' Disease.  Submitted, 1993.

174.           Solomon B, Wartofsky L, Burman KD.  Management of Differentiated Thyroid Carcinoma: Results of a Survey of American Thyroid Association Members Submitted, 1993.

175.           Burch HB, Sellitti D, Barnes SG, Nagy EV, Bahn RS, Burman KD.  Identification and Partial Characterization of Proteins Immunologically Related to the Thyrotropin Receptor in Cultured Human Retroocular Fibroblasts.  J Clin Endocrinol Metab 78: 1384-1391, 1994

176.           Lasswell WL, Burman KD.  "Thyroid Function Tests and Methods of Imaging the Thyroid Gland."  In: McDermott MT (ed), Endocrinology Secrets.  Philadelphia: Hanley and Belfus, 1994.

177.           Duncan WE, Burman KD.  Bone densitometry. Precision error is low.  BMJ 308: 1567, 1994.

178.           Loughney MH, Burman KD.  "Unusual Forms of Thyrotoxicosis".  Advances in Endocrinology and Metabolism.  Mosby Year Book, Inc., 5:349-392, 1994.

179.           Burch H, Solomon BL, Wartofsky L, and Burman KD.  "Discontinuing Antithyroid Drug Therapy before Ablation with Radioiodine in Graves Disease".  Ann Int Med, 121:553-614, 1994.

180.           Burman, KD. How serious are the risks of thyroid hormone over replacement? Thyroid Today XVIII, October-December, 1995.

181.           Atwa MA, Lukes YD, Salata K, Abo-Hashem EM, El-Kannishy MH, Burman KD.  The influence of triiodothyronine, thyroxine, thyrotropin and methimazole on thyroid cell MHC Class II antigen expression.  Clinical Immunology and Immunopathology.  76: 209-213, 1995.

182.           Kushner J and Burman KD.  Can catabolism be reversed and survival enhanced by altering glucose, somatostatin, and glucagon levels in systemically ill patients?  Critical Care Medicine.  23(1):1-2, January 1995.

183.           Burman KD.  Thyroid Cancer I.  Endocrinology and Metabolism Clinics of North America, 24 (4), 1995.

184.           Burman KD.  How serious are the risks of thyroid hormone over-replacement?  Thyroid Today, XVIII:(4), 1995.

185.           Burch HB, Wartofsky L, Burman KD. Antithyroid drugs and radioiodine therapy.  Ann Intern Med 122: 554-555, 1995.

186.           Atwa MA, Smallridge RC, Burch HB, Gist ID, Lu R, Abo-Hashem EM, El-Kannishy MH, and Burman KD.  Immunoglobulins from Graves' Patients Stimulate Phospholipase A2 and C Systems in FRTL-5 and Human Thyroid Cells.  European J of Endocrinology, 135: 322-327, 1996.

187.           Solomon BL, Wartofsky L, Burman KD.  Current Trends in the Management of Well Differentiated Papillary Thyroid Carcinoma, Journal of Clinical Endocrinology & Metabolism, 81:(1), 1996.

188.           Burman, KD.  Does T3 mediate cold adaption? (Editorial) Submitted.  January 20, 1996.

189.           Burman KD.  Is triiodothyronine administration beneficial in patients undergoing coronary artery bypass surgery?  JAMA, 275:  723, 1996.

190.           Burman KD, Ringel MD and Wartofsky L.  Unusual Types of Thyroid Neoplasms.  Endocrin & Metabol Clinics of NA, 25:49-68, 1996.

191.           Burman KD.  Does T3 Mediate Cold Adaptation?  Editorial, Endocrin & Metabol, 3: 1-5,1996.

192.           Tseng YL, Lahiri S, Nicholson D, Burman KD and Wartofsky L. Evidence of an association of endothelin-1 receptor expression to the active growth phase of the cell cycle and identification of endothelin-1 mRNA in FRTL5 cells.  Endocrin & Metabol, 3:37-47, 1996.

193.           Burman KD.  How does thyroid hormone alter nutrient and energy metabolism?  Endocrine & Metabol (Editorial), 3:215-217, 1996.

194.           Burch HB, Burman KD, Reed HL, Bucker L, Raber T and Ownbey JL.  Fine Needle Aspiration of Thyroid Nodules.  Determinants of insufficiency rate and malignancy yield at thyroidectomy.  Acta Cytologica, 40:1176-83, 1996.

195.           Smallridge RC, Tsokos GC, Burman KD, Porter L, Cranston T and Solomon BL.  Soluble Interleukin-2 Receptor is a thyroid hormone dependent early response marker in the treatment of thyrotoxicosis.  Clinical and Diagnostic Laboratory Immunology 4: 583-586, 1997.

196.           Burman KD.  Graves' Ophthalmopathy:  What is the initial abnormality?  European J of Endocrinology, 136:  583-585, 1997.

197.           Burman KD.  Thyroid Disease and Osteoporosis.  Hospital Practice, 32: 71-86, 1997.

198.           Burman KD.  Immunoassays, Nonradionucleotide.  Encyclopedia of Human Biology, 4:701-706, 1997.

199.           Ringel MD, Taylor T, Barsouk A, Wall JR, Freter CE, Howard RS, Diehl L, Burman KD. Hodgkin’s disease treated with neck radiation is associated with increased antibody dependent cellular cytotoxicity against human extra ocular muscle cells.  Thyroid 7: 425-432, 1997.

200.           Prendiville S, Burman KD, Wartofsky L, Ringel MD and Sessions RB.  Evaluation and treatment of post thyroidectomy hypocalcemia.  The Endocrinologist 8: 34-40, 1998.

201.           Burman KD, Pandian R.  Clinical utility of assays for TSH receptor antibodies.                The Endocrinologist 8: 284, 1998.

202.           Burch HB, Barnes S, Nagy EV, Sellitti D, Burman KD, Bahn RS, Lahiri S.  Immunodetection of manganese superoxide dismutase n cultured human retro ocular fibroblasts using sera directed against the thyrotropin receptor. J Endocrinol Invest. 21:48‑55, 1998.

203.           Pacak K, Sweeney DC, Wartofsky L, Mark AS, Punja U, Azzam CJ, Burman KD. Solitary cerebellar metastasis from papillary thyroid carcinoma; a case report.  Thyroid 8: 327-335, 1998.

204.           Lu R, Wang P, Wartofsky L, Sutton BD, Zweier JL, Bahn RS, Garrity J, Burman KD. Oxygen free radicals in IL-1 beta induced glycosaminoglycan production by retro ocular fibroblasts from normal and patients with Graves’ Ophthalmopathy.  Thyroid 9:297-303, 1999.

205.           Wartofsky L, Burman KD, Ringel MD.  Trading one "dangerous dogma" for another? J Clin Endocrinol Metab. 84:1759‑60, 1999.

206.           Ringel MD, Balducci-Silano P, Anderson JS, Spencer CA, Silverman J, Sparling YH, Francis GL, Burman KD, Wartofsky L, Ladenson PW, Levine MA, Tuttle RM. Quantitative reverse transcription-polymerase chain reaction of circulating thyroglobulin    messenger ribonucleic acid for monitoring patients with thyroid carcinoma. J Clin Endocrinol Metab. 84: 4037-4042, 1999.

207.           Ringel MD, Burman KD, Shmookler BM. A Clinical aspect of miscellaneous and unusual cancers of the thyroid@ in Thyroid Cancer: A comprehensive guide to clinical management edited by Wartofsky L, Humana Press, New Jersey, 1999.

208.           Burman KD, Wartofsky L.  Iodine Effects on the Thyroid Gland: Biochemical and Clinical Aspects.  In Reviews in Endocrine and Metabolic Disorders, Kluwer Academic   Publishers, Volume 1, Issue 2, in press. Co-Editor, Reviews in Endocrine and Metabolic   Disorders, Volume 1, Issues 2 and 3, Thyroid Diseases, Editorial comment in each issue.

209.           Burman, KD, Graves’ Disease and Thyroid hormone changes in the intensive care unit setting.  Two chapters In Principles and Practice of Endocrinology and Metabolism, editor KL Becker, J.B. Lippincott Co, Philadelphia.

210.           Burman KD.  Thyroid disease and osteoporosis.  Hospital Practice 32:71-86, 1997.

211.           Burman KD, Becker RL, Cytryn A, Goodglick T, Graves’ disease, Chapter 7,  in Atlas of Clinical Endocrinology, Current Medicine, Philadelphia, 1999.

212.           Burman KD, Hypothyroidism, Medscape. Com, Dec 1999.

213.           Prendiville S, Burman KD, Ringel MD, Shmookler BM, Deeb ZE, Wolfe K, Azumi N, Wartofsky L, Sessions RB.  Tall cell variant:  an aggressive form of papillary thyroid carcinoma.  Otolaryngology Head Neck, Mar 2000 122(3):352-7

214.           Newkirk KA, Ringel, Jelinek JJ, Mark A, Wartofsky L, Deeb ZE, Beaudet L, Burman, KD.  Ultrasound guided fine-needle aspiration and thyroid disease. Otolaryngol. Head and Neck Surg. 123:700-705, 2000.

215.           Gardner R, Tuttle RM, Burman KD, Haddady S, Truman C, Wartofsky L, Sessions RB, Ringel MD.  Prognostic importance of vascular invasion in papillary thyroid carcinoma. Arch Otolaryngol Head Neck Surg. 126: 309-312, 2000.

216.           Ringel MD,  Greenberg M, Chen X, Hayre N, Suzuki K, Priebat D, Saji M, Burman KD. Cytotoxic activity of 2’,2’-difluorodeoxycytidine (Gemcitabine) against poorly differentiated human thyroid carcinoma cells. Thyroid. 10:865-9, 2000.

217.           Burman KD, Wartofsky L. Iodine Effects on the Thyroid Gland: Biochemical and Clinical Aspects.  Endocrine & Metabolic Disorders. 1:19-25, 2000.

218.           Fadel BM, Ellahham S, Ringel MD, Lindsay Jr., Joseph, Wartofsky L, Burman KD, Hyperthyroid Heart Disease, Clin. Cardiol, 23:402-408, 2000.

219.           Wartofsky L, Ringel MD, Burman KD. Therapy of Graves' Ophthalmopathy. Chapter 19 pages 257-278. in Graves' Disease: Pathogenesis and Treatment, Kuwer Academic Publishers, Boston, 2000.

220.           Kazlauskaite R, Weintraub BD, Burman KD. Evaluation of thyroid function tests/ Chapter 48 Pages 2821-2829 in Kelley's Textbook of Internal Medicine, Fourth Edition, Edited by H. David Humes, Lippincott Williams and Wilkins, New York, 2000.

221.           Thomas, J. Taylor, Susan S. Donlon, Allen E Bale, Robert C. Smallridge, Thomas B. Francis, Reed S. Christensen, and Kenneth D. Burman. Treatment of a Thyrotropinoma with Octreotide-LAR in a Patient with Multiple Endocrine Neoplasia – 1.  Thyroid, 10:1001-1007, 2000.

222.           Newkirk KA, Ringel MD, Wartofsky L, Burman KD. The Role of Radioactive Iodine in Salivary Gland Dysfunction. Ear, Nose, & Throat Journal. 79(6):460-8, 2000.

223.           Burman KD, Cooper DS.  The Diagnostic Evaluation and Management of Hyperthyroidism due to Graves’ Disease, Toxic Nodules and Toxic Multinodular Goiter.  In Medical Management of Thyroid Disease (Chapter 2; pages 33-92), edited by Cooper DS, Marcel Dekker, Inc., New York, 2001.

224.           Burman KD, Wartofsky L.  Thyroid function in the intensive care unit setting.  Crit Care Clin.  2001 Jan;17:43-57, 2001.

225.           Burman KD.  Graves’ Disease in Women. Proper therapy depends on an accurate diagnosis. Women’s Health in Primary Care. 2001 April (4) 4:306-308.

226.           Ringel MD, Hayre N, Saito J, Saunier B, Schuppert F, Burch H, Bernet V, Burman KD, Kohn LD, Saji M. Overexpression and overactivation of Akt in thyroid carcinoma. Cancer Res 61: 6105-6111, 2001.

227.           Stathatos N. Levetan C. Burman KD. Wartofsky L. The controversy of the treatment of critically ill patients with thyroid hormone. Best Practice & Research Clinical Endocrinology & Metabolism. 15:465-78, 2001.

228.           Ringel MD, Hardy E, Bernet VJ, Burch HB, Schuppert F, Burman KD, Saji M. Rapid Communication: Metastin Receptor is Overexpressed in Papillary Thyroid Cancer and Signals through MAP Kinase in Thyroid Cancer Cells. J Clin Endocrinol Metabol. 2002; 87:2399-2402